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Studies of Miniature Tear Glucose Sensors and Electromodulated  










Chair: Mark E. Meyerhoff 
 
In this dissertation, classic enzyme-based electrochemical sensors were fabricated 
for tear glucose measurements.  Moreover, electrochemically modulated nitric oxide 
(NO) delivery systems were investigated to potentially improve the biocompatibility of 
indwelling medical devices. 
First, miniature amperometric and coulometric biosensors were coupled with a 
glass micro-capillary to detect low levels (0.62 μM and 0.32 μM, S/N=3, respectively) of 
glucose in 3 microliters of tear fluid. The sensors were employed to selectively measure 
tear glucose in anesthetized rabbits with insulin administration over a wide range of 
blood glucose values.  A positive correlation (r
2
=0.86 and 0.83 for 
 xviii 
amperometric and coulometric sensors) between the glucose levels in tear fluid and blood 
was found. This method may provide a supplementary tool to aid routine point-of-care 
blood glucose monitoring. 
Nitric oxide (NO) plays critical roles in platelet inhibition, vasodilation, and 
antimicrobial activity.  Two novel electromodulated approaches were studied to deliver 
NO on demand from a reservoir of donor species.  Nitric oxide was previously reported 
to be the common product produced from electrochemical reduction of various S-
nitrosothiols (RSNO) at physiological pH.  However, studies here show that RSNO 
species are reduced to nitrous oxide (N2O), not NO, at pH 7.4.  Interestingly, at pH 4.0, a 
proton coupled one-electron reduction of RSNOs takes place and generates quantitative 
NO release on a gold working electrode.  Therefore, it is further demonstrated that it is 
possible to use a reservoir of RSNOs at low pH to create catheters that can 






 to possibly 
prevent clotting and infection. 
In addition, pH sensitive NO donors, inorganic nitrite salts and diazeniumdiolated 
species, were employed to design a controlled NO release catheter via electrochemical 
modulation.   Protons produced by water oxidation can lower the local pH and release 
NO in a thin layer in proximity to an anode surface.  Catheters filled with NO donor 
solutions and a simple two-electrode circuit are shown to be able to electrochemically 













1.1 Role of Electrochemistry in Modern Medicine 
 
Since Clark and Lyons proposed the first concept of an enzyme based electrode 
for glucose measurement in 1962,
1
 electrochemical sensing has developed into a 
relatively mature field that continuously remains an active area of research with 
combined efforts of biologists, physicists, chemists, and engineers.  The use of 
electrochemical techniques, in which the potential, current, or charge in an 
electrochemical cell serves as the signal for analytical methods has been widely explored.  
Electrochemical sensors are advantageous in measurement science, including 
environmental analysis and clinical diagnosis, due to various inherent properties.  For 
example, they are relatively inexpensive, capable of real-time monitoring, and are easy to 
miniaturize and ultimately be implanted to facilitate in vivo tests without complex sample 
preparations.  They also possess the ability to enhance selectivity and sensitivity by 
electrode modification and/or applied electrochemical methods optimization.  




1. Potentiometry is a method that measures the potential difference between two 
electrodes.  It is based on a reversible recognition between the target analyte (usually 
an ionic species) and a receptor under zero-current conditions.  In theory, the 
potential (E) observed is proportional to the activity (a) of the target ion in the sample 
(Nernst equation,     
      
 
       K: constant, z: charge of ion, T=25 ).  As 
examples, the classic pH electrode and K
+
 sensors are routinely employed in modern 
clinical lab analyzers.
2
  Further, simple Ag/AgCl electrodes are generally applied to 
measure electrical signals associated with heart function (e.g., EKG or ECG). 
2. Amperometry includes measuring the electrochemical reduction or oxidation 
current with a constant voltage applied to the system.  The steady-state current is 
directly related to the concentration of analyte.  Many commercial handhold glucose 
meters are amperometric devices.  In addition, the Clark style oxygen sensor
3
 can be 
made as an implantable biomedical amperometric device.  
3. Voltammetry monitors the current from electrochemical reactions (similar to 
amperometry) but with application of varying applied voltage.  Usually, three 
electrodes are required, including the working, reference, and auxiliary electrodes.   
Two main types of voltammetric methods are cyclic voltammetry and linear sweep 
voltammetry, and other methods include stripping analysis and pulsed voltammetry as 
well.  In principle, pulsed and square wave voltammetry techniques are suitable for 
lower concentration applications due to their excellent signal to noise ratios when 
compared to cyclic voltammetry or linear sweep voltammetry.  Further, the anodic 
stripping voltammetry method is commonly employed in clinical microarray 
3 
 
analyzers to detect lead and other toxic heavy metal ions with high sensitivity in 
complex biological samples (blood, urine, and saliva).
4
  
4. Coulometry is a technique that integrates the electrical currents passed through 
two electrodes in contact with the test solution, and the total electrical charge is 
correlated to the concentration of target species.  This method counts the absolute 
amount of charge generated in the system, and therefore, in theory, does not need 
calibration.  It is an attractive tool for environmental applications when fast response, 
low detection limit, and easy operation are required.
5
   
5. Impedance is a method that reveals the capacitive properties and charge-transfer 
kinetics of an electrode under electrochemical perturbations/reactions.  It generally 
employs a series of sinusoidal voltages that is close to the formal potential (with 
amplitude of 5-20 mV) to the working electrode with variable frequencies.  This 
technique provides a powerful tool to reach extremely low detection limit in 




In this dissertation, a special interest of research is focused on employing classic 
amperometric and coulometric sensors for unconventional glucose measurements in 
microliter volumes of accessible tear fluid.  Further, the feasibility of creating an 
electrochemically modulated nitric oxide delivery method to prevent clotting and 





1.2 Non/Minimally Invasive Glucose Measurements 
According to current statistics from the World Health Organization (WHO), an 
estimated 346 million people have diabetes mellitus worldwide.  Diabetes has been well 
recognized as one of the major causes of death and disabilities in developed countries, 
and the mortality rate of individuals diagnosed with diabetes is expected to double by 
2030.
7
  Early diagnosis and tight glycemic management are crucial in helping to prevent 
and control diabetes and its complications, such as cardiovascular disease, kidney failure, 
and blindness.
8, 9
   
Conventional point-of-care glucose monitoring systems generally involve finger 
pricks to obtain drops of blood to be analyzed with an electrochemical strip-based 
glucometer.  The sample volume of blood is drawn into a test strip loaded with glucose 
oxidase or glucose dehydrogenase, which reacts with sample glucose and reports a 
reading of plasma glucose concentrations in a few seconds.  For Type 1 diabetics, it is 
recommended that their blood glucose concentration be monitored up to eight times a day.  
These repeated finger pricks may result in patient discomfort and, therefore, less frequent 
blood glucose checks that can lead to further complications.
10, 11
 
1.2.1 Current Research on Non-Invasive Glucose Measurements 
A number of new techniques have been examined that might provide a minimally 
invasive and/or non-invasive approach to blood glucose monitoring to improve patient 









 and a photonic 
crystal method.
17
  Unfortunately, none of these techniques have yet achieved the required 
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analytical performance necessary to fully substitute for conventional blood glucometer 
devices.  Other investigations have suggested testing glucose levels in accessible 









viable alternatives to finger pricks. 
Most notably, a commercial automatic glucose monitor called the GlucoWatch
®
 2 
Biographer (Cygnus Inc., Redwood City, CA) received United States Food and Drug 
Administration (FDA) approval in 2001.  It measured glucose continuously from 
subcutaneous fluid that was brought to the skin surface by reverse iontophoresis via 
application of a small electric voltage. An AutoSensor composed of a replaceable 
adhesive polymer pad was placed at the back of the device to collect interstitial fluids that 
further undergo an enzymatic reaction with glucose oxidase at an electrochemical sensor 
surface, similar to the traditional glucometer (Figure 1.1).  It automatically measured 




Figure 1.1. Schematic diagram of the ionotophoresis process during an interstitial glucose measurements 
using GlucoWatch.  
 
However, clinical researchers reported only a 78.4% correlation coefficient 
(p<0.05) between these automated measured glucose values and a finger-prick 
glucometer.
24
  Due to poor accuracy, the device required repeated calibration every 5 
measurements.  Further, according to the FDA, at least half of the users experienced skin 
irritation or itching from the electric discharge, and thus the patients had to rotate the 
device site so as to avoid repeated skin irritation.  Sweating was recognized as another 
factor that led to additional inaccuracy.  Due to the lack of reliability and accuracy, the 
GlucoWatch
®
 G2 Biographer system is no longer produced, effective July 31, 2007.   
There are also other approved and readily commercially available continuous 
glucose monitoring (CGM) systems.  They are usually operated to measure interstitial 
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glucose levels for up to a few days at a time until the glucose sensor needs to be replaced, 
while the patients continues daily activities at home.  These include: (1) the Navigator 
CGM device (Abbott Diabetes Care, Alameda, CA); (2) the Seven Plus (DexCom, San 
Diego, CA); and (3) the Guardian (Medtronic Diabetes, Northridge, CA).  These 
continuous glucose monitoring system provide a very helpful tool for tight glycemic 
control and predicting necessary therapeutic treatment.  However, these available systems 
must be coupled with the conventional finger-prick glucometer to be calibrated each day, 
or multiple times per day.  In addition, the glucose levels measured in interstitial fluids 




The use of urine samples for the estimation of blood glucose concentrations has 
received considerable attention.  This method is non-invasive and particularly useful for 
people who are unable to use a blood glucometer or that reside in rural areas in 
developing countries.  It usually involves the use of a special reagent strip or dipstick that 
contains color-sensitive reagents to react with glycosuria (glucose in urine).  The color 
developed on the strip provides quantitative information of detected glycosuria levels by 
referring to a standard color scale.  A more recent study, using gold nanoparticles with 
immobilized glucose oxidase, measured urine glucose at a lower threshold of 0.56 mM 
(10 mg/dL), and a color change from red to blue that can be differentiated by the naked 
eye.  However, the preparation is complicated, requiring gold nanoparticle fabrication 
and enzyme immobilization.
22
  Also, glucose will only show up in the urine once it has 
reached high levels in the blood, i.e. 10 mM (180 mg/dL), which is already a pathological 
value.  Additionally, urine is a complex sample matrix and the correlation between 
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glycosuria and blood sugar is possible only if renal plasma flow and filtration is normal; 
in case of reduced plasma flow, the renal glucose threshold will be higher.  As a result, a 
glycosuria test is not an ideal alternate to routine blood glucose monitoring and diabetic 
treatments.   
1.2.2 Tear Fluid as Surrogate for Glucose Measurements 
Tear fluid has unique properties among other accessible body fluids and is known 
to contain glucose.
26
  Compared to saliva and urine that have a variable dilution effects, 
tear fluid that bathes the eye is maintained at a miniscule and relatively stable volume (~4 
μL). Tear fluid is continuously replenished by the lacrimal gland and other accessory 
glands at a rate of production in the range of 0.5-2.2 μL/min.
27
  A thin film of tear fluid 
(~8 μm thick) keeps the cornea and conjunctiva continuously moist, without any 
stimulation (Figure 1.2).
28
   
 
 
Figure 1.2. Schematic diagram of the eye and tear production. 
The interest in monitoring glucose levels in tear fluid dates back to 1937 when 
Michail et al. demonstrated an increase of tear glucose concentration in diabetics.
29
  Tear 
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glucose measurements provide the possibility of developing a relatively simple and 
minimally invasive method of monitoring glucose levels, provided that the tear glucose 
concentrations can be shown to correlate closely to the blood glucose concentrations in 
individuals.  If a good correlation between the two types of samples can be established 
over a wide glycemic range, tear glucose monitoring could be an attractive alternate for 
conventional blood glucose measurements within the normal (4-6 mM) as well as 
hyperglycemic and hypoglycemic ranges.  During the measurement, it is important for 
tear fluid to be collected using a method that will not impact/perturb the eye or cause any 
damage to the blood capillaries within the eye.  Indeed, it is necessary to prevent any 
capillary glucose leakage into the tear film that would result in false high glucose levels 
compared to the actual glucose present in the tear fluid.  Furthermore, tear fluid must be 
collected in a manner that will not increase tear production, which would further dilute 
the glucose concentrations in such samples.   
1.2.3 Current Research on Tear Glucose Measurements 
There has been much research focused on the determination of glucose in tears 
with different methods.  For any technique to be effective, it requires a low detection 
limit, since glucose is present at levels of 50-100 times lower than in blood,
28
 high 
selectivity over active interferences such as uric acid and ascorbic acid,
30
 and the ability 
to quantitatively measure small sample volumes in a short time period (1-5 min).  While 
most of the studies reported to date have found a positive correlation between tear and 
blood glucose levels, discrepancies still exist in terms of the actual lacrimal glucose 
concentrations (7-600 µM) and the degree of correlation between blood and tear levels, 
10 
 
mainly due to different tear glucose measurement and sampling methods (e.g., filter 
paper and micro-capillaries). 
31-33
    
LeBlanc et al.
32
 reported a tear glucose concentration analysis system using high-
performance liquid chromatography with a pulse amperometric detector (HPLC-PAD).  
They concluded from 44 paired samples from 5 patients that poor correlation existed 
between tear and blood glucose in critically ill patients, and that glucose measurement in 
tear fluid failed to provide an alternative method to blood glucose monitoring.  Later, 
Lane
28
 applied a similar chromatographic (LC-PAD) system in 121 diabetic and non-
diabetic patients and found a correlation between tear glucose and capillary blood glucose 
concentrations.  In a recent paper, La Belle and co-workers
34
 introduced a disposable 
microfluidics system that measured glucose at levels as low as 43.4 µM using an 
integrated electrochemical sensor.  The authors proposed this device to be a future 
prototype for a non-invasive glucose testing, but did not provide real sample data.  An 
enzyme immobilized Pt electrode on the surface of a poly-dimethyl silicone (PDMS) was 
reported to be able to measure tear glucose levels in a rabbit to be 0.12 mmol/L.
35
  
However, no blood samples were collected to validate any relationship between tear and 
blood glucose levels.   
In perhaps the most significant studies to date, Baca and Asher
36
 employed liquid 
chromatography coupled with electrospray ionization mass spectrometry (LC-ESI-MS) to 
detect glucose concentrations in 1 µL samples of tear fluid.  They were able to obtain 
significant correlations between this method and a contact lens-based sensor device.  In 
fact, attempts to continuously monitor tear glucose concentrations using disposable 
contact lenses have received much research focus as most diabetic patients have 
11 
 
complications that need visual correction as well.
37
  In 2004, March and co-workers 
published the first clinical trial test of five fasting Type 2 diabetic patients using a 
fluorescent contact lens tear glucose sensor, where the fluorescent signal increases with 
higher concentrations of  glucose in tear fluid.  The tear glucose levels measured in a 3 h 
experiment by the lens sensor tracked the trend of blood glucose well.
38
  Later, the Asher 
and other research groups developed a series of photonic crystal glucose sensing 
materials for the non-invasive tear glucose monitoring system.
39-41
    An intelligent 
platform of polymerized crystalline colloidal array (PCCA) was employed.  The PCCA 
consists of highly ordered crystalline colloidal material that responds to the volume 
changes of the hydrogel on the principle that the observed diffraction wavelength is 
directly related to the spacing between lattice planes.
40
  Therefore, by tethering the 
boronic acid molecule which can reversibly recognize glucose to the hydrogel materials, 
a contact lens optical sensor was created.  By proper design, a change of color as a 
function of glucose concentration occurs based on a change in the diffraction properties 
of the lens material as glucose binds to the anchored boronic acid sites.  One major 
challenge in the boronic acid doped contact lens system is the complex receptor design 
and the need for irradiation to initiate the diffraction based color change.   
Despite these and other research efforts, discrepancies exist on whether there is a 
clinically useful correlation between tear glucose and blood glucose, as well as a stable 
true concentration of tear glucose in normal and diabetic subjects.  Consequently, more 
research is needed to develop more sensitive detection techniques and less invasive 
sampling methods that can be used very close to the patient, so that evaporation or other 
issues associated with very small tear sample volumes can be prevented.  
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1.3 Nitric Oxide (NO) and NO Precursors 
1.3.1 Biological Functions of NO 
Since nitric oxide (NO) was first discovered as the elusive endothelial-derived 
relaxing factor (EDRF) in 1987,
42
 there has been a significant research effort to explore 
and understand the many other important physiological activities of NO.
43
  
Nitric oxide is the smallest biological messenger in the human body.
43
  It 
functions as a vasodilator, an inhibitor of platelet adhesion and activation, an 
antimicrobial mediator and a neurotransmitter.
44
  Endothelial cells (EC) that line the inner 
surfaces of all blood vessels possess an enzyme that produces NO called NO synthase 
(eNOS).  The mechanism for NO production starts with a two-electron oxidation of L-
arginine in the presence of oxygen and one molecule of NADPH, forming a N-hydroxy-
L-arginine intermediate.  Thereafter, a three-electron oxidation occurs, which is 
supported by oxygen and 0.5 molecule of NADPH, resulting in the formation of L-
citrulline and NO in a 1:1 stoichiometry (Figure 1.3, left).
45
   Once the diatomic radical is 
synthesized in the endothelium, it can diffuse into underlying smooth muscle cells and 
further activates soluble guanylyl cyclase, ultimately resulting in the relaxation of smooth 
muscle cells and promoting vessel dilation (Figure 1.3, right).  Further, emission of NO at 
the blood/surface interface is critically important since the local levels of NO produced 
by the endothelium prevents platelet activation and adhesion to this highly 
thromboresistant surface.  However, NO does not exist to any significant degree in blood 
due to its rapid reaction with oxyhemoglobin (to form methemoglobin and nitrate) and its 




Figure 1.3. Scheme of production and biological functions of NO in human blood.  
1.3.2 NO Donors: S-Nitrosothiols, Diazeniumdiolates, and Nitrite Salts 
S-Nitrosothiols (RSNOs) have proven to be a potent donor of transient NO with 
much better stability and longer half-life (most RSNOs are stable for hours in the 
presence of metal ion chelator).
46
  The functions of RSNOs mirror that of NO in 
biological processes including vasodilation, contraction of heart and skeletal muscle, and 
neurotransmission.
47
  For instance, RSNOs have been shown to increase in response to 
inflammatory stimuli
48
 and also are elevated in septic shock.
49
  Up to now, normal plasma 
RSNOs have been detected over a wide range of concentrations, from trace nanomolar to 
tens of micromolar levels,
47
 due to differences in the individual species as well as the 
sampling and analytical methodologies used.   
Endogenous RSNOs are formed in vivo from the reaction between thiols and NO, 
or its reactive intermediates.  A fraction of NO produced by NOS in the vasculature 
(approximately 20%) escapes inactivation by hemoglobin and is oxidized to HNO2 (Eq. 
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1.1) and subsequently N2O3 (Eq. 1.2), which spontaneously decomposes to produce nitrite 
(NO2
-
) and nitrosonium ions (NO
+
) (Eq. 1.3).  The NO
+  
serves as a nitrosating agent, and 
can react with free thiols (including cysteine residues within proteins) to form  low 
concentrations of S-nitrosothiols (Eq. 1.4).
50
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        Scheme 1.1. Reactions leading to the formations of endogenous RSNOs. 
Chemically, RSNOs are thioesters of nitrite with the nitroso moieties covalently 
bound to a sulfhydryl group (Figure 1.4).  S-Nitrosothiols are assumed to act as stable 
stores of NO and can release local transient NO under physiological conditions via 
different decomposition pathways (thermal, light, thiol, catalytic metal ion reduction, 
etc.). Hence, there are increasing research interests to utilize such NO generating 
processes in order to modify different surfaces with RSNOs and then release NO in a 




Figure 1.4. Chemical structures of some S-nitrosothiols (RSNOs) 
 
N-Diazeniumdiolates, compounds containing two molecules of NO combined 
with an amine (N) or other nucleophilic site, which are called NONOates, were first 
investigated by Drago in the 1960s.
51, 52
  Later in the 1990s, with the discovery of NO’s 
important biological functions, diazeniumdiolates became an ideal NO precursor 
candidate for proton-mediated NO release to tackle pharmacological and biomedical 
research problems.
53, 54
  Diazeniumdiolates are usually prepared via exposing primary or 
secondary amine compounds to NO gas at an elevated pressure (i.e., 5 atm).
55
  
Diazeniumdiolates have a generic structure of R1R2NN(O)=NOR3 (Figure 1.5), with rich 
structural diversity allowing for the design of different derivative groups with various 
half-lives and NO release rates.  
For example, depending on the identity of the R3 groups, diazeniumdiolates can 





  Some zwitterionic salts have to undergo metabolism and/or hydrolysis to remove 






























choosing the proper R3 groups that can be specifically cleaved by certain enzymes, a cell 
or organ selective NO releasing agent can be prepared.
57, 58
  On the other hand, some 
anionic diazeniumdiolate salts have been widely employed as potent NO precursors to 
achieve the release of NO when exposed to aqueous media.
59
  Figure 1.5 illustrates some 
examples of diazeniumdiolates and their half-lives (in pH 7.4 phosphate buffer at 37°C), 
as used in this dissertation work. 
 
Figure 1.5. Structures and half-lives (t1/2) in pH 7.4 phosphate buffer at 37˚C of some diazeniumdiolates. 
 
The release of NO from diazeniumdiolates is proton and/or thermally driven. 
Therefore, exposure of these NO precursors to physiological conditions will stimulate 
NO release.  Figure 1.6 depicts the NO releasing mechanism from anionic 




Figure 1.6. The proton driven NO releasing mechanism from anionic diazeniumdiolates. 
 
In biology, the inorganic anion, nitrite, is generally viewed as the oxidative end-
product of endogenous NO metabolism.  However, recent studies from two independent 
groups have shown that nitrite can recycle in vivo to form NO through the protonation of 
nitrite in the stomach.
60, 61
   These were the first two reports on NOS-independent NO 
formation.  More importantly, they represent an alternative source of endogenous NO, 
especially under hypoxia conditions, when the classic oxygen-dependent NO generation 
from L-arginine/NO synthase may be dysfunctional.  Nitric oxide levels in the stomach 
are in the range of 10-100 ppm, several orders of magnitude higher than required for 
vasodilation.  At such high concentrations, the gastric NO is toxic to a wide range of 
microorganisms, and may function as a possible antibacterial agent.  The researchers 
tested this hypothesis by exposing pathogenic Enterobacteriaceae E. Coli and C. Albicans 
to the combination of acids and nitrite, and found them to be destroyed.
61
  A more recent 
study by Bjorne and co-workers investigated the antibacterial effect of human gastric 
juice mixed with saliva, with a high concentration of nitrite in saliva.
62
  These studies 
have provided good indications that nitrite and NO play an important role in gastric host 
defense against swallowed pathogens. 
When nitrite (pKa 3.4) is acidified, it produces nitrous acid (HNO2, Eq. 1.5) first, 
which spontaneously decomposes to NO and nitrogen dioxide (NO2). (Eq. 1.6 and 1.7) 
18 
 
      
                                        (   ) 
                                            (   ) 
                                                  (   ) 
         Scheme 1.2. NO release mechanism from nitrite acidification. 
 
1.4 Anti-Thrombotic and Anti-Bacterial Medical Devices with NO Release  
As mentioned above, nitric oxide is a potent anti-thrombotic and anti-bacterial 
agent that functions widely in the cardiovascular and immune systems at various 
concentrations (ppb to ppm levels).  Therefore, synthetic polymer materials that can 
mimic the nature of endothelial cells (EC) to release localized NO at equal or greater 
fluxes to that of the EC will enable the preparation of potentially thrombus resistant and 
bactericidal surfaces.  By immobilizing NO delivery coatings onto clinically relevant 
blood-contacting and implantable medical devices (i.e., vascular grafts, intravascular 
catheters and sensors, extracorporeal blood-loop, oxygenators etc.), the risk of thrombus 
formation and inflammation/infection can be reduced, and ultimately the in vivo 
performance and life-time of such devices can be improved. 
1.4.1 Current Methods of Continuous Nitric Oxide Release 
Indeed, over the past two decades, there have been considerable research efforts 
on the design of polymeric materials with NO releasing/generating properties, mainly 
based on incorporating NO precursors into a variety of polymers including poly(vinyl 
chloride) (PVC), polyurethane (PU), silicone rubber (SR), and polymethacrylate (PM).  
19 
 
The amount of local NO flux and the release rates can be modulated by changing the 
chemical structure of NO precursors and/or polymer backbones.  To effectively modify 
these polymer matrices with NO releasing/generation function, two different approaches 
have been pursued: (1) incorporation of discrete NO precursor (i.e., diazeniumdiolate and 
RSNO) species into films of the hydrophobic polymers; or (2) covalently tethering of NO 
release agents onto the backbone of the given polymer.   
In 1996, the Smith and Keefer group reported the first diazeniumdiolate based NO 
releasing polymers using both of the two above mentioned methods.
63
  Diethylamine 
NONOate and spermine NONOate were blended into poly(ethylene glycol) (PEG) and 
poly(caprolactone) (PCL) matrices and the resulting polymers retained the active NO 
releasing surface over 5 to 7 weeks of storage as a solid under ambient conditions.  By 
incorporating diazeniumdiolates into hydrophobic polymer solids of low hydrogen ion 





blended zwitterionic diazeniumdiolated dimethylhexane diamine (DMHD/NONOate) 
into different polymer matrices to achieve continuous NO release for 10-72 h when 
incubated at 37  in PBS.  By dip coating the surface of an implantable oxygen catheter 
with a diazeniumdiolated doped silicone rubber, superior analytical accuracy and 
significantly reduced thrombus formation was observed on the coated catheter surface as 
compared to the control catheter without the NO release coating.  Zhou et al.
66
 
synthesized water-soluble diazeniumdiolated poly(ethylenimine) (PEI) for its potential 
use as an NO release agent within the dialysate fluid in hemodialysis systems.  By tuning 
the specific structure of the polymer and the use of exogenous additives (i.e., sodium salt 
of poly(acrylic acid) to accelerate NO releasing rate of high molecular weight PEI 
20 
 
NONOate), the polymers were able to provide steady and well controlled physiological 






) through the fiber of dialysis devices. 
In addition to diazeniumdiolated NO releasing materials, RSNOs have also been 
employed as an active precursor to generate localized NO from hydrophobic polymer 
materials.  The labile nitroso bond of RSNO molecules can be decomposed and release 
NO via various pathways, including pH, light, heat, and catalytic metal ions.
67
  Copper 
ion (Cu (II)/Cu (I)) is one of the most widely utilized catalytic reagents,
68, 69
 in the 
presence of a reducing agent such as thiols.  A slow reduction of Cu (II) by the thiols to 
form Cu (I) (Eq. 1.8) can further reduce RSNO into RS
-
 and NO free radicals, with the 
regeneration of thiolate and Cu (II) (Eq. 1.9) at the same time, yielding a catalytic cycle.  
Therefore, only a trace amount of copper ion is needed to release NO from RSNOs.
69
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Scheme 1.3. Copper (I/II) ion mediated catalytic NO generation from RSNO species. 
 
Our laboratory has previously investigated the feasibility of both doping 
hydrophobic PVC polymers with lipophilic copper complexes
70
 as well as covalently 
linking a Cu (I/II)-cyclen complex into a polymethacrylate matrix for the in situ 
generation of nitric oxide from endogenous RSNOs in blood.
71
  The potential advantage 
of employing catalytic polymeric materials in vivo is that the NO generated from local 
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endogenous RSNO species are likely to be sustained, provided the subject maintains a 
constant RSNO supply (assumed to be μM levels) by blood circulation.   
Besides metal ions, certain enzymes have also been reported to be able to 
decompose RSNOs to NO.  One example is glutathione peroxidase (GPx), a peroxidase 
found in erythrocytes of mammals that reduce lipid hydroperoxides to their 
corresponding alcohols, and therefore help prevent lipid peroxidation of the cell 
membrane.  The crystal structure of GPx shows the enzyme contains 4 subunits, each 
with a selenocysteine residue in a depression on the surface.  Studies have shown that 
GPx can activate GSNO to liberate NO in the presence of H2O2.
72
  Further studies 
suggested that diselenides along with free thiols can also catalyze the decomposition of 
RSNO into NO in a stepwise manner.
73
  The initial activation is assumed to involve the 
interchange reaction of the diselenide and the thiol (Eq. 1.10).  The selenolate generated 
from first step further reacts with RSNO to release NO (Eq. 1.11 and Eq. 1.12).  The first 
three reactions represent the stepwise catalytic cycle with the presence of thiol, R’SH, as 
the reducing agent and diselenide being a catalyst.  Equation 1.13 occurs even without the 
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Scheme 1.4. Organoselenium species mediated catalytic NO generation from RSNO. 
Cha and Meyerhoff reported the first NO generating polymer matrix (i.e., 
cellulose filter paper and polyethylenimine) with immobilized organoselenium species to 
mimic GPx and observed the catalytic decomposition of endogenous RSNO into NO with 
the corresponding free thiol.
74
  Later, Yang and co-workers
75
 assembled a universal NO 
generating surface via the Layer-by-Layer coating of sodium alginate and 
organoselenium modified polyethyleneimine on polymeric substrates.  A stable and 






) was generated from a quartz slide coated with 
(SePEI/Alg)10 even after prolonged contact with sheep whole blood (24 h at 4 ).  More 
recently, Cai et al.
76
 synthesized an aromatic carboxyl-ebselen based polyethylenimine 
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film that was assembled via the Layer-by-Layer technique onto quartz slide and 
polyurethane catheters.  The catalytic film was able to continuously generate 
physiological levels of NO from RSNO after blood soaking, suggesting the potential 
application as an anti-thrombotic and anti-bacterial coating for medical devices.  
However, one potential obstacle of employing the catalytic NO generating system in 
clinical applications is the various concentrations of RSNO species available in the blood 
stream for each individual subject, as the actual endogenous blood RSNO levels 




1.4.2 Current Methods to Modulate Nitric Oxide Release 
There is an increasing interest in the development of new NO releasing materials 
capable of liberating NO at a predictable rate.  Indeed, rapid and precise spatial and 
temporal control of localized NO release will allow fundamental studies to define useful 
NO fluxes required to achieve specific therapeutic effects.  However, to the best of our 
knowledge, most reported studies employed continuous modes to release or generate NO. 
For example, the release of NO is initiated once a diazeniumdiolated polymer is exposed 
to aqueous media, and the NO releasing flux can only be roughly tuned by switching to 
different polymer materials or using different structures of NO donors.  This usually 
involves complex synthesis work to ultimately formulate the ideal polymer-precursor 
compositions.  Further, the life time of a diazeniumdiolate based NO releasing system is 
also greatly limited by the initial reservoir of NO precursors.  Moreover, since the 
endogenous concentration of RSNOs varies, this is an issue for the long term NO 
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generating system.  Therefore, more work is needed in order to maintain truly long term 
active NO releasing/generating polymers.  
Previous research in the Meyerhoff lab has incorporated synthetic RSNOs into a 
polymer matrix through covalent linkage and it was shown that controlled fluxes of NO 
can be emitted from the polymers by exposure to light through a homolytic cleavage of 
the S-N bond.
79
  More specifically, the photo-switchable NO releasing material was 
prepared with synthetic RSNO (S-nitroso-N-acetyl-DL-penicillamine) modified fumed 
silica particles that were further doped into silicone rubber films.  Notably, the specific 
amount of NO flux can be controlled by the intensity of light.  The on/off light trigger is 
environmentally friendly, readily available and easily manipulated, providing an elegant 
tool to deliver NO into biological sites on demand. 
Recently, our group has also utilized electrochemical techniques in thin films of 
polymeric materials to create and modulate the release of NO at physiologically relevant 
levels based on the reduction of nitrite ions at the surface of copper electrodes.
80
   Hofler 
and colleagues created a novel catheter configuration filled with a concentrated and 
buffered sodium nitrite precursor (pH 6.8), along with a copper working electrode and a 
Ag/AgCl reference electrode inserted in the catheter lumen.  The control of the potential 
applied to the Cu electrode can “turn on” and “turn off” the release of NO through the 
walls of the 1 mm diameter catheter tubing.  A cathodic pulse at at -0.7 V (vs. NHE) to 
refresh the Cu
o
 surface, followed by another positive potential step at +0.2 V (vs. NHE) 
to produce Cu
+
 that can react with nitrite to release NO (Eq. 1.14).   
       
                                        (    ) 
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In theory, an ca. 150 μm thick layer of nitrite solution on a copper mesh or copper 






 NO flux 
continuously for 100 days in a planar or cylindrical arrangement.  The catheter was tested 
over a week in a biofilm dispersion study and showed that the electromodulated catheter 
that releases NO had 97% less viable E. coli on its surfaces.  At the same time, a 98% 







) from the catheter surface. 
Active and modulated release of NO from polymer surfaces used to prepare 
indwelling catheters can be extremely valuable in extending the longevity of catheter 
placement with a given supply of NO precursors.  The ability to switch on/off the NO 
release may help to yield extended lifetimes since it is not necessary to have a continuous 
flux of NO to kill biofilm forming microbes. 
1.4.3 Nitric Oxide Detection via Chemiluminescence 
The analytical evaluation of nitric oxide  release from devices/materials is quite 
challenging due to NO being a free radical, with unique physical and chemical properties, 
such as rapid diffusion, high reactivity, short half-life, and a broad range of local 
concentrations (picomolar to micromolar) in physiological milieus.
81
  Despite these 
difficulties, a variety of analytical approaches have been employed for the detection of 




 and fluorescence-based 
spectroscopic techniques,
84








An ozone-based chemiluminescence method is by far the gold standard for the 
detection of NO released from materials due to its reliability, accuracy and sensitivity.
87
    
The released NO gas is continuously purged with nitrogen gas and is carried with a 
sweep nitrogen gas into an reaction chamber.  Here, NO then undergoes a rapid oxidation 
reaction in the gas phase with ozone and yields nitrogen dioxide (NO2*) in an excited 
state.  As the excited electron returns to its ground state, a photon is emitted and is 
detected as chemiluminescence.  The emitted light is detected and amplified by a 
photomultiplier tube (PMT) (Figure 1.7).  Such a method can detect NO at concentration 
as low as 0.5 ppb, with a dynamic range up to ~500 ppm.
81
   
 
 
Figure 1.7. Schematic representation of the chemiluminescence NO measurement setup.
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1.5 Statement of Research 
In this dissertation, the design of enzyme-based non/minimally invasive 
electrochemical tear glucose sensors coupled with a glass micro-capillary fluid collection 
configuration is proposed as a potential supplementary tool for routine point-of-care 
glycemic management.  In addition, this thesis work has focused on developing a new 
electrochemically modulated approach to deliver NO to a given site at physiological 
levels from NO precursor species residing in silicone rubber catheter tubing. 
Chapter 2 introduces two simple needle-type enzyme electrode devices 
(amperometric and coulometric) to selectively detect tear glucose in anesthetized rabbits 
with insulin administration to achieve a wide range of blood glucose values (2-20 mM).  
A positive correlation between glucose levels in tear fluids and blood was found using 
this animal model.  However, the slope of correlation varies from animal to animal.  This 
suggests that the ratio between blood and tear glucose varies significantly from animal to 
animal.  Therefore, to ultimately use tear fluid as an alternate sample to evaluate blood 
glucose for human subjects, the approach will likely require a pre-calibration step to 
obtain the exact ratio between blood and tears for each individual.  Once this correlation 
is established for a given eye, the proper algorithm can be employed for the reported tear 
glucose results in order to reflect a corresponding value of blood glucose.  Eventually, a 
disposable single use strip-type sensor that is similar to the commercial blood glucometer 




Chapter 3 reexamines previous literature on NO being the reported common 
product generated from the direct electrochemical reduction of various RSNOs at 
physiological pH.  However, headspace gas analysis using infrared absorption 
spectroscopy suggests that RSNO species are electrochemically reduced to nitrous oxide 
(N2O) at pH 7.4, and can only be converted back to NO by switching to a more oxidizing 
applied voltage.  Interestingly, at pH 4.0, a proton coupled one-electron reduction of 
RSNOs appears to take place and generates quantitative NO release at a gold working 
electrode at a cathodic potential of -0.8 V (v.s. Ag/AgCl).  Based on preliminary results 
obtained, it seems possible to use a reservoir of RSNOs at this lower pH to create 
biomedical devices (e.g., intravascular catheters) in which electrochemically modulated 
release of NO can be achieved to prevent clotting and infection.  
Chapter 4 describes a novel method that utilizes proton driven NO release from 
inorganic nitrite salts and diazeniumdiolated species to electrochemically modulate the 
NO flux from biomedical catheters.  This was achieved by lowering the local pH by 
generating protons from water oxidation in a thin layer in close proximity to an anode 
surface.  Silicone rubber catheters filled with such NO precursor solutions, as well as a 







) of NO by voltammetric control for up to 8 h. 
Chapter 5 summarizes the findings and conclusions of this dissertation work and 
provides an outlook for future directions.  Improvements of the tear glucose sensor 
configuration that would require less than 1 μL tear fluid for future human tests are 
discussed.  Future long term experiments and biological studies on the anti-thrombotic 
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and anti-bacterial applications for the electrochemical modulated NO releasing catheters 




1. L.C. Clark and C. Lyons, Ann. N.Y. Acad. Sci., 1962, 102, 29-45. 
2. H.F. Osswald, R. Asper, W. Dimai, and W. Simon, Clin. Chem., 1979, 25, 39-43. 
3. L.C. Clark, R. Wolf, D. Granger, and Z. Taylor, J. App. Physiol., 1953, 6, 189-
193. 
4. W. Yantasee, Y. Lin, K. Hongsirikarn, G.E. Fryxell, R. Addleman, and C. 
Timchalk, Environ. Health Perspect., 2007, 115, 1683-1690. 
5. H.B. Yildiz and L. Toppare, Biosens. Bioelectron., 2006, 21, 2306-2310. 
6. J. Baur, C. Gondran, M. Holzinger, E. Defrancq, H. Perrot, and S. Cosnier, Anal. 
Chem., 2009, 82, 1066-1072. 
7. http://www.who.int/mediacentre/factsheets/fs312/en/index.html. 
8. M. Muggeo, Diabetic Medicine, 1998, 15, S60-S62. 
9. Y. Zhao, W. Ye, K.S. Boye, J.H. Holcombe, and R. Swindle, Diabetic Medicine, 
2009, 26, 61-69. 
10. C.L. Gay, F. Chapuis, N. Bendelac, F. Tixier, S. Treppoz, and M. Nicolino, 
Diabetes & Metabolism, 2006, 32, 159-165. 
11. S. Greene, Medicine, 2002, 30, 60-65. 
12. A. Sämann, C. Fischbacher, K.U. Jagemann, K. Danzer, J. Schüler, L. Papenkordt, 
and U.A. Müller, Exp Clin Endocrinol Diabetes, 2000, 108, 406-413. 
13. D. Abookasis and J.J. Workman, J. Biomed. Opt., 2011, 16, 027001-027009. 
14. N. Dingari, I. Barman, G. Singh, J. Kang, R. Dasari, and M. Feld, Analytical and 
Bioanalytical Chemistry, 2011, 400, 2871-2880. 
15. R. Ballerstadt, C. Evans, A. Gowda, and R. McNichols, Diabetes Technol. Ther., 
2006, 8, 296-311. 
16. R. Weiss, Y. Yegorchikov, A. Shusterman, and I. Raz, Diabetes Technol. Ther., 
2007, 9, 68-74. 
17. J.H. Holtz, J.S.W. Holtz, C.H. Munro, and S.A. Asher, Anal. Chem., 1998, 70, 
780-791. 
18. S. Woderer, N. Henninger, C.-D. Garthe, H.M. Kloetzer, M. Hajnsek, U. 




19. E. Cengiz and W.V. Tamborlane, Diabetes Technol. Ther., 2009, 11, S-11-S-16. 
20. M. Yamaguchi, M. Mitsumori, and Y. Kano, IEEE Eng. Med. Biol. Mag., 1998, 
17, 59-63. 
21. J. Lu, R.F. Bu, Z.L. Sun, Q.S. Lu, H. Jin, Y. Wang, S.H. Wang, L. Li, Z.L. Xie, 
and B.Q. Yang, Diabetes Research and Clinical Practice, 2011, 93, 179-186. 
22. C. Radhakumary and K. Sreenivasan, Anal. Chem., 2011, 83, 2829-2833. 
23. J.G. Lewis, British Medical Journal, 1957, 1, 585. 
24. S.Y. Rhee, S. Chon, G. Koh, J.R. Paeng, S. Oh, J.-t. Woo, S.W. Kim, J.-W. Kim, 
and Y.S. Kim, J Korean Med Sci, 2007, 22, 70-73. 
25. B. Wilhelm, S. Forst, M.M. Weber, M. Larbig, A. Pfūtzner, and T. Forst, 
Diabetes Technol. Ther., 2006, 8, 146-155. 
26. S. Iwata, International Ophthalmology Clinics, 1973, 13, 29-46. 
27. Y. Ohashi, M. Dogru, and K. Tsubota, Clinica Chimica Acta, 2006, 369, 17-28. 
28. J.D. Lane, D.M. Krumholz, R.A. Sack, and C. Morris, Current Eye Research, 
2006, 31, 895-901. 
29. D. Michail and N. Zolog, C. R. Soc. Biol., Paris, 1937, 126, 1042. 
30. C.K.M. Choy, I.F.F. Benzie, and P. Cho, Invest. Ophthalmol. Vis. Sci., 2000, 41, 
3293-3298. 
31. R. Chen, Z. Jin, and L.A. Colon, J. Cap. Elec., 1996, 3, 243-248. 
32. J. LeBlanc, C. Haas, G. Vicente, and L. Colon, Intensive Care Medicine, 2005, 31, 
1442-1445. 
33. D.K. Sen and G.S. Sarin, Br. J. Ophthalomol., 1980, 64, 693-695. 
34. J.T. LaBelle, D.K. Bishop, S.R. Vossler, D.R. Patel, and C.B. Cook, J. Diabetes 
Sci. Technol., 2010, 4, 307-311. 
35. M.X. Chu, T. Shirai, D. Takahashi, T. Arakawa, H. Kudo, K. Sano, S. Sawada, K. 
Yano, Y. Iwasaki, K. Akiyoshi, M. Mochizuki, and K. Mitsubayashi, Biomed. 
Microdevices, 2011, 13, 603-611. 
36. J.T. Baca, C.R. Taormina, E. Feingold, D.N. Finegold, J.J. Grabowski, and S.A. 
Asher, Clin. Chem., 2007, 53, 1370-1372. 
37. J.T. Baca, D.N. Finegold, and S.A. Asher, The Ocular Surface, 2007, 5, 280-293. 
32 
 
38. W.F. March, A. Mueller, and P. Herbrechtsmeier, Diabetes Technol. Ther., 2004, 
6, 782-789. 
39. V.L. Alexeev, S. Das, D.N. Finegold, and S.A. Asher, Clin. Chem., 2004, 50, 
2353-2360. 
40. M.M.W. Muscatello, L.E. Stunja, and S.A. Asher, Anal. Chem., 2009, 81, 4978-
4986. 
41. H. Yao, A.J. Shum, M. Cowan, I. Lähdesmäki, and B.A. Parviz, Biosens. 
Bioelectron., 2011, 26, 3290-3296. 
42. L.J. Ignarro, G.M. Bugga, K.S. Wood, R.E. Byrns, and G. Chaudhuri, Proc. Natl. 
Acad. Sci. U.S.A., 1987, 84, 9265-9269. 
43. E. Culotta and D.E.K. Jr., Science, 1992, 258, 1862-1865. 
44. M. Feelisch and J. Stamler, Methods in Nitric Oxide Research. 1996: John Wiley 
& Sons. 
45. H. Al-Sa'Doni and A. Ferro, Clinical Science, 2000, 98, 507-520. 
46. N. Hogg, Free Radi. Biol. Med., 2000, 28, 1478-1486. 
47. D. Giustarini, A. Milzani, R. Colombo, I. Dalle-Donne, and R. Rossi, Clin. Chim. 
Acta, 2003, 330, 85-98. 
48. J.H. Crawford, b.K. Chacko, H.M. Pruitt, B. Piknova, N. Hogg, and R.P. Patel, 
Blood, 2004, 104, 1375-1382. 
49. S.J. Kuhl and H. Rosen, West J. Med., 1998, 168, 176-181. 
50. S. Shiva, X. Wang, L.A. Ringwood, X. Xu, S. Yuditskaya, V. Annavajjhala, H. 
Miyajima, N. Hogg, A.L. Harris, and M.T. Gladwin, Nat. Chem. Biol., 2006, 2, 
486-493. 
51. R.S. Drago, R.O. Ragsdale, and D.P. Eyman, J. Am. Chem. Soc., 1961, 83, 4337-
4339. 
52. R.S. Drago and F.E. Paulik, J. Am. Chem. Soc., 1960, 82, 96-98. 
53. J.E. Saavedra, G.J. Southan, K.M. Davies, A. Lundell, C. Markou, S.R. Hanson, 
C. Adrie, W.E. Hurford, W.M. Zapol, and L.K. Keefer, J. Med. Chem., 1996, 39, 
4361-4365. 
54. D.J. Waterhouse, J.E. Saavedra, K.M. Davies, M.L. Citro, X. Xu, D.A. Powell, 
G.J. Grimes, G.K. Potti, and L.K. Keefer, J. Pharm. Sci., 2006, 95, 108-115. 
33 
 
55. J.A. Hrabie, J.R. Klose, D.A. Wink, and L.K. Keefer, J. Org. Chem., 1993, 58, 
1472-1476. 
56. M.M. Reynolds, M.C. Frost, and M.E. Meyerhoff, Free Radi. Biol. Med., 2004, 
37, 926-936. 
57. J.E. Saavedra, P.J. Shami, L.Y. Wang, K.M. Davies, M.N. Booth, M.L. Citro, and 
L.K. Keefer, J. Med. Chem., 1999, 43, 261-269. 
58. A.E. Maciag, H. Chakrapani, J.E. Saavedra, N.L. Morris, R.J. Holland, K.M. 
Kosak, P.J. Shami, L.M. Anderson, and L.K. Keefer, J. Pharmacol. Exp. Ther., 
2011, 336, 313-320. 
59. K.M. Davies, D.A. Wink, J.E. Saavedra, and L.K. Keefer, J. Am. Chem. Soc., 
2001, 123, 5473-5481. 
60. J.O. Lundberg, E. Weitzberg, J.M. Lundberg, and K. Alving, Gut, 1994, 35, 1543-
1546. 
61. N. Benjamin, F. O'Driscoll, H. Dougall, C. Duncan, L. Smith, and M. Golden, 
Nature 1994, 368, 502. 
62. H. Björne, E. Weitzberg, and J.O. Lundberg, Free Radi. Biol. Med., 2006, 41, 
1404-1412. 
63. D.J. Smith, D. Chakravarthy, S. Pulfer, M.L. Simmons, J.A. Hrabie, M.L. Citro, 
J.E. Saavedra, K.M. Davies, T.C. Hutsell, D.L. Mooradian, S.R. Hanson, and L.K. 
Keefer, J. Med. Chem., 1996, 39, 1148-1156. 
64. K.A. Mowery, M. H. Schoenfisch, J.E. Saavedra, L.K. Keefer, and M.E. 
Meyerhoff, Biomaterials, 2000, 21, 9-21. 
65. M.H. Schoenfisch, K.A. Mowery, M.V. Rader, N. Baliga, J.A. Wahr, and M.E. 
Meyerhoff, Anal. Chem., 2000, 72, 1119-1126. 
66. Z. Zhou, G.M. Annich, Y. Wu, and M.E. Meyerhoff, Biomacromolecules, 2006, 7, 
2565-2574. 
67. D.L.H. Williams, Acc. Chem. Res., 1999, 32, 869-876. 
68. S.C. Askew, D.J. Barnett, J. McAninly, and D.L.H. Williams, J. Chem. Soc., 
PERKIN TRANS 2, 1995, 1995, 741-745. 
69. A.P. Dicks, H.R. Swift, D.L.H. Williams, A.R. Butler, H.H. Al-Sa'doni, and B.G. 
Cox, J. Chem. Soc., PERKIN TRANS 2, 1996, 1996, 481-488. 
70. B.K. Oh and M.E. Meyerhoff, J. Am. Chem. Soc., 2003, 125, 9552-9553. 
34 
 
71. S. Hwang, W. Cha, and M.E. Meyerhoff, Angew. Chem. Int. Ed., 2006, 45, 2745-
2748. 
72. J.E. Freedman, B. Frei, G.N. Welch, and J. Loscalzo, J. Clin. Invest., 1995, 96, 
394-400. 
73. Y. Hou, Z. Guo, J. Li, and P.G. Wang, Biochem. Biophys. Res. Comm., 1996, 228, 
88-93. 
74. C. Wansik and M.E. Meyerhoff, Biomaterials, 2007, 28, 19-27. 
75. J. Yang, J.L. Welby, and M.E. Meyerhoff, Langmuir, 2008, 24, 10265-10272. 
76. W. Cai, J. Wu, C. Xi, A.J. Ashe Iii, and M.E. Meyerhoff, Biomaterials, 2011, 32, 
7774-7784. 
77. Y. Wu, F. Zhang, Y. Wang, M. Krishnamoorthy, P. Roy-Chaudhury, B.E. Bleske, 
and M.E. Meyerhoff, Clin. Chem., 2008, 54, 916-918. 
78. Y. Wu, W. Cha, F. Zhang, and M.E. Meyerhoff, Clin. Chem., 2009, 55, 1038-
1040. 
79. M. Frost and M.E. Meyerhoff, J. Am. Chem. Soc., 2004, 126, 1348-1349. 
80. L. Hofler, D. Koley, J. Wu, C. Xi, and M.E. Meyerhoff, RSC Advances, 2012, 2, 
6765-6767. 
81. E.M. Hetrick and M.H. Schoenfisch, Annu. Rev. Anal. Chem., 2009, 2, 409-433. 
82. J.N. Bates, Neuroprotocols, 1992, 1, 141-149. 
83. E.M. Boon and M.A. Marletta, J. Am. Chem. Soc., 2006, 128, 10022-10023. 
84. A. Gomes, E. Fernandes, and J.F.C. Lima, J. Fluoresc., 2006, 16, 119-139. 
85. P. Kuppusamy, R.A. Shankar, V.M. Roubaud, and J.L. Zweier, Magn. Reson. 
Med., 2001, 45, 700-707. 
86. Y. Lee, B.K. Oh, and M.E. Meyerhoff, Anal. Chem., 2004, 76, 536-544. 








EVALUATION OF ENZYME-BASED TEAR GLUCOSE 
ELECTROCHEMICAL SENSORS OVER A WIDE RANGE OF BLOOD 
GLUCOSE CONCENTRATIONS 
 
2.1      Introduction 
 
As discussed in Chapter 1, non-invasive glucose monitoring systems have an 
unmet need in modern medicine for tight glycemic management of diabetes.  Among the 
accessible fluids for minimal invasive and/or non-invasive glucose measurement, 
miniature tear glucose sensor devices may provide an attractive supplement to 
conventional blood glucometer measurements, provided that the tear glucose 
concentrations can be shown to correlate with blood glucose concentrations over a wide 
range of glucose concentrations. 
Tear fluid that bathes the eye is maintained at a miniscule and relatively stable 
volume (~4 μL).  It is continuously replenished by the lacrimal gland and other accessory 
glands at a rate of production in the range of 0.5-2.2 μL/min.
1
  A thin film of tear fluid 
(~8 μm thick) keeps the cornea and conjunctiva continuously moist, without any 
stimulation.   
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Previous research efforts on measuring tear glucose concentrations have reported 
varying lacrimal glucose levels (7-600 μM),
2, 3
 and whether a close correlation between 
blood glucose and tear glucose concentrations exists is still debatable.  This is mainly due 
to the different measurement methodologies and tear fluid sampling methods employed.   
Indeed, the exact tear collection method is of importance for lacrimal glucose 
measurement.
4
 An increased tear production from physical or chemical stimulation will 
secrete more aqueous tear volume and, therefore, falsely lower the glucose levels (via 
dilution).  In addition, decreased tear elimination caused by dysfunction of the tear 
drainage system (lacrimal puncta) will also lead to accumulation of aqueous tear volume 
and consequently, lower tear glucose concentrations.  On the other hand, loss of the lipid 
layer from physical or chemical perturbation will result in increased tear osmolarity and 
decrease the basal tear volumes.
5
  Therefore, careful design of the device used for 
collecting tear fluid from the meniscus of the lower eye lid without irritating the eye is 
essential for accurate tear glucose measurements.  To date, the major sampling tools 
applied include filter paper strips,
6
 glass capillary tubes,
7
 plastic capillary tubes,
8




Surprisingly, even though the conventional hand-held glucometers are primarily 
based on the electrochemical/enzymatic detection of glucose in tiny volumes of whole 
blood, to date there are very few reports on applying electrochemical devices for tear 
glucose measurements.  Our group has previously proposed a small amperometric sensor 
for tear glucose measurement in 5 μL tear fluids and found a very positive correlation 
between tear and blood glucose levels using 12 anesthetized rabbits over a period of 8 
h.
11
  However, it is known that anesthesia will elevate blood glucose levels.
12
  Therefore, 
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the correlation could only be validated in the high blood glucose concentrations range in 
all tested animals.   
Herein, we employ a similar needle-type enzyme-based amperometric sensor as 
well as a newer coulometric enzyme electrode configuration for the detection of tear 
glucose within a micro glass capillary tube requiring only 3 µL of tear fluid.  The sensors 
were applied to detect tear glucose concentrations in anesthetized rabbits, but now with 
insulin administration to achieve a much broader range of blood glucose values (2-20 
mM).  Using the miniature electrochemical devices, good correlations in glucose levels 
between the two types of samples is observed, suggesting that tear glucose measurement 
may provide an attractive supplementary method to current blood glucose self-monitoring 
devices.  
 
2.2. Materials and Methods 
 
2.2.1 Materials 
Glucose oxidase (Type VII, from Aspergillus niger), D-(+)-glucose, 
glutaraldehyde, bovine serum albumin, sodium chloride, sodium phosphate dibasic, 
potassium hydroxide, potassium chloride, potassium phosphate monobascic, L-ascorbic 
acid, uric acid (sodium salt), acetaminophen, 1,3-diaminobenzene, resorcinol,  and 
Nafion (5 wt% solution in a lower aliphatic alcohols/H2O mix) were purchased from 
Sigma-Aldrich (St. Louis, MO) and used without further purification.  Platinum/iridium 
and silver wires with Teflon
®
 coatings were obtained from A-M Systems (Sequim, WA).  
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Heat shrinkable tubing was product of Advanced Polymers (Salem, NH).  Micro glass 
capillary tubes were obtained from Drummond (Broomall, PA). 
2.2.2 Fabrication of Tear Glucose Sensors 
The sensing devices are based on immobilizing glucose oxidase on a Pt/Ir wire 
and anodically detecting the liberated hydrogen peroxide from the enzymatic reaction 
(Figure 2.1).  Inner selective layers of Nafion
®
 and an electropolymerized film of 1,3-
diaminobenzene/resorcinol greatly enhance the selectivity for glucose over known 
electroactive interferents, including ascorbate, urate and acetaminophen.
13
  The 
amperometric sensor was fabricated from the Teflon
®
 coated Pt/Ir (wt%, 95:5) with 1 mm 
active cavity of the exposed Pt wire providing a total working area of 0.40 mm
2
.  At the 
same time, a coulometric sensor configuration was designed similarly except that a larger 
surface area on the Pt/Ir working electrode was exposed and covered with active layers 
(including enzyme) so that substantial consumption of glucose can take place during 
measurements within the capillary tubes.   Indeed, for the coulometric device, 10 mm of 
the Pt/Ir (of 80 mm total) wire with an area of 4.0 mm
2 
was exposed to the sample as the 
working electrode.  The Ag/AgCl reference/auxiliary electrode was prepared by dipping 
an 8 cm bare Ag (from a 16 cm Teflon coated Ag wire) into a 0.2 M FeCl3 in 1 M HCl 
solution. Ten layers of glucose oxidase (5% in Bovine Serum Albumin) crossed-linked 
with another 5 layers of glutaraldehyde (2.5% in PBS) was alternately dip coated onto the 
coulometric Pt electrode surface.  With these sensor configurations, 3 µL of calibrating 
solution or tear fluid is required and collected into marked micro capillary tubes (0.58 
mm i.d.), and the sensor is then inserted.   
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Figure 2.1.  a) Schematic representation of the tear glucose detection in a glass capillary. b) Configuration 
of the amperometric sensor. c) Configuration of the coulometric sensor. 
 
2.2.3 Calibration of Tear Glucose Sensors 
The amperometric and coulometric sensors were calibrated using a four-channel 
BioStat potentiostat (ESA Biosciences Inc., Chelmsford, MA).  After fabrication, the 
sensor was polarized at +0.6 V (vs. Ag/AgCl) in pH 7.4 phosphate buffered saline (PBS) 
for 3 h to reach a steady baseline.  Three μL of glucose standard solution of varying 
concentrations (5-800 μM) were collected with a 0.58 mm i.d. microliter glass capillary 
tube (World Precision Instruments, Sarasota, FL) by capillary action. The bottom tip of 
the capillary was then sealed with a Critoseal wax (McCormick Scientific, Richmond, 
FL).  It should be noted that the volume of test solution does not need to be precisely 
controlled in the amperometric measurement, but it has to be an exact 3 μL volume of 
solution for the coulometric test.  The sensors were then carefully inserted into the 
capillary from the top opening without destroying the enzyme layer, especially for the 
amperometric sensor.  For amperometric sensor, after the oxidation current was acquired 
for 5 min, a steady state current was recorded, and the sensor was removed from the glass 
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capillary and rinsed with deionized water for the next measurement of a higher 
concentration of glucose solution.  A calibration curve was generated by plotting the 
recorded currents vs. the glucose concentrations.  Generally, a linear regression fit is 
observed for the amperometric design.  For the coulometric sensor, the oxidation current 
was also recorded and timed for 5 min after the sensor was exposed to the glucose 
solution (or tear fluid) within the capillary.  Then the total electric charge passed through 
the working (Pt) and reference (Ag/AgCl) electrode in contact with the glucose solution 
was calculated by integrating the area under the i-t (current-time) response curve.  In 
addition, the selectivity of sensor was examined in solutions of interfering species at their 
highest possible concentrations (i.e., 100 μM ascorbic acid, 100 μM uric acid, and 10 μM 
acetaminophen in PBS) in tear fluid.  The % error that would occur in samples containing 
these levels of interferences was calculated by dividing the reported current from each 
interfering species by that observed from a 100 μM of glucose standard solution. 
 
2.2.4 Rabbit Study Protocol 
A total of 17 white rabbits (Myrtle’s Rabbitry, Thompson’s Station, TN) were 
used in this study to test the correlation of glucose levels between tear and blood samples 
over a wide range of blood glucose concentrations.  A modified animal anesthesia 
protocol was applied based on previously reported studies
11
 with the additional use of 
insulin.  Further, in order to collect fresh tear fluids for each measurement, the rabbit was 
rested at a prone position so that any freshly produced tear fluid was guided from the 
lacrimal canal into the tear sac and nasal passage.  Human insulin (Sigma, St. Louis, MO) 
was prepared by dissolving 1.45 mg into 10 mL 0.001 N HCl, then further diluted to 100 
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mL with saline, to make a 0.4 U/mL solution.  One bolus of insulin (0.4 U/mL in saline, 
0.4 mL) was given 1 h after anesthesia commenced, and additional boluses were 
employed as needed in order to reduce blood glucose levels to less than 5 mM in each 
rabbit.  Every 30 min, 0.5 mL blood was drawn from the rabbit’s carotid artery and the 
glucose concentration was measured by a Radiometer whole blood analyzer (Radiometer 
America Inc., Westlake, OH).  At the same time, 3 μL of rabbit tear fluid was collected 
into the glass capillary and the current from the given type of glucose sensor placed into 
the tear fluid was recorded using the Biostat potentiostat.  In each rabbit experiment, 12 
pairs of blood glucose and tear glucose concentration data points were recorded for 7 h.  
Similarly as in the prior calibration step, for the amperometric sensors, the steady-state 
current value was recorded 5 min after the sensor was inserted into the capillary tube 
containing the tear fluid.  For the coulometric sensor, the current over 5 min was 
integrated to provide the total charge, and this value was used to calibrate and also 
determine the concentration of glucose in the tear samples.    The sensors were calibrated 
one day prior to the rabbit study and then re-calibrated in capillary tubes with standard 
glucose solution (200 μM in PBS) at the end of the 7 h experiment, and this calibration 
point was used to back calculate the rabbit tear glucose levels.  Statistical data analysis 
was carried out to examine the correlation between the blood and tear glucose values 






2.3. Results and Discussion 
2.3.1 Analytical Performance of Amperometric Sensor 
The amperometric sensor is based on a previous subcutaneous implantable 
glucose sensor design,
14
 except that the outer polymer coating which restricts the glucose 
diffusion in high glucose concentrations for blood sample measurement was removed.   
Here, in order to achieve the low detection limit required for tear measurements, the 
enzymatic layer is in direct contact with glucose molecules in tear fluid.  Typical 
response and calibration curves of the amperometric device are presented in Figure 2.2.  
The sensor exhibits a fast response to reach the steady-state current over a wide range of 
glucose concentrations (5-800 μM, Figure 2.2a), with an average sensitivity of 0.10±0.01 
nA/μM of glucose (n=3).  It is capable of achieving a detection limit of 0.62±0.03 µM 
(S/N=3, n=3), which provides the ability to detect very low levels of lacrimal glucose in 
tear samples.  In addition, to reliably detect glucose concentrations in the tear fluid 
sample at a potential of +0.6 V (vs. Ag/AgCl), the sensor must exhibit good selectivity 
over electroactive species that can be present in tear fluid, such as ascorbic and uric acids, 
which will be oxidized and induce error in the detected glucose levels.  Indeed, the 
concentration of ascorbic acid and uric acid in tear fluid are reported to be ~20 μM and 
70 μM, respectively.
13
  Therefore, we tested the amperometric response of the sensor 
towards 100 μM of uric acid and 100 μM of ascorbic acid, and 10 μM of acetaminophen 
as a small neutral interfering species (20 times lower than in blood, assuming a similar 
tear-blood dilution ratio as glucose).  Due to the presence of underlying Nafion
®
 layer 
and the electropolymerized layer of 1,3-diaminobenzene/resorcinol, the amperometric 
sensor exhibited excellent selectivity over these potentially interfering species, with the 
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error percentages of 2.1%, 5.8%, and 2.5% for ascorbic acid, uric acid, and 
acetaminophen, respectively.  This provides a good indication that the amperometric 
devices can selectively respond to glucose without significant interference from these 
antioxidant species present in tear fluid. 
 
Figure 2.2.  Calibration of tear glucose sensor using 3 μL solution in capillary.  (a) Solutions in the order of 
5 μM, 10 μM, 30 μM, 50 μM, 150 μM, 300 μM, 500μM, 800μM glucose. Inset: Interferents and low-end 
(5-50 μM) glucose response (note: the sensor is rinsed with water and soaked briefly in PBS buffer between 
each placement in capillary tube containing the test interferent or standard.)  (b) Resulting calibration curve 
of tear glucose sensor. Inset: Low-end glucose calibration (5-50 μM).  Error bars represent s.d. of n=3 
replicate measurements of each standard within capillary tubes. 
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2.3.2 Analytical Performance of Coulometric Sensor 
The coulometric glucose sensor design was developed in order to detect very low 
levels of glucose in tear fluid that may arise from the new insulin protocol that was 
implemented in this study.  The coulometry approach provides a more convenient 
analytical method for future applications, potentially without the need for calibration, as 
well as enhanced sensitivity.  Compared to the amperometric glucose sensor, there are 
two major differences in the new coulometric sensor design.  The larger exposed 
enzymatic area on the Pt/Ir working electrode (4.0 mm
2
) and the dip-coated enzyme layer 
of the coulometric sensors improve the efficiency for collection of peroxide produced 
from glucose.  Indeed, this design employs a thinner enzyme layer and, therefore, it 
enhances the diffusion of glucose and peroxide to the electrode surface.  Overall, the 
larger surface area of the sensor increases the surface to volume ratio, which greatly 
increases the rate of consumption of the glucose in the entire 3 μL sample within the 
capillary. 
For small volume tear glucose testing, it is important to complete a glucose 
measurement in a reasonably short time period (1-5 min).  A useful way of reducing 
response time is to accelerate the overall kinetics of the enzymatic reaction and diffusion 
by increasing temperature.  Figure 2.3 shows representative response curves of the 
coulometric sensor at normal room temperature of 25⁰C and at an elevated temperature of 
50⁰C.  Indeed, a much faster coulometric current decay at the higher temperature 
suggests glucose in the sample solutions are consumed and depleted in a shorter time than 




Figure 2.3. Response of coulometric tear glucose sensor using 3 μL solutions in capillary at RT (dotted line, 
25⁰C) and elevated temperature (solid line, 50 ⁰ C), solutions in the order of 10 μM, 50 μM, 200 μM, 800 
μM glucose. 
 
Further, by using the same electrode but acquiring and integrating data over 
different time periods, it is possible to compare the percentage of sample consumption 
over time (Figure 2.4).  As shown, at 50⁰C, 100% of glucose was depleted at the end of 
each 20 min measurement at various concentrations, and 71.5% of glucose was consumed 
within 5 min data acquisition time, while 52.7% of sample was depleted within a 3 min 
interval.  Therefore, during the sensor calibration and real sample measurements, the 
temperature was raised to 50⁰C and the total charge was acquired over a 5 min 
measurement period.   Faster depletion rates of glucose should be possible with further 






Figure 2.4. Calibration of coulometric tear glucose sensor using 3 μL solutions in capillary at elevated 
temperature (50 ⁰ C), with different data acquisition time periods: 3 min (solid circle), 5 min (hollow circle), 
20 min (triangle). 
 
 
The typical calibration curve for the coulometric tear glucose sensor in capillary 
tubes under this optimal higher temperature and shorter measurement time conditions (5 
min) is shown in Figure 2.5.  The sensor is capable of achieving a wide dynamic range 
(10-800 µM) and a very low detection limit of 0.38±0.13 µM (S/N=3, n=3) for the 
coulometric design.  The coulometric sensor was then employed in rabbit studies along 
with the amperometric sensor to monitor tear fluid glucose levels.  The measured tear 
glucose concentrations were compared with the results obtained with the amperometric 
sensors in order to examine whether the two methods provide similar correlations 





Figure 2.5.  Calibration of coulometric tear glucose sensor using 3 μL solutions in capillary.  (a) Solutions 
in the order of 100 μM ascorbic acid, 10 μM acetaminophen, 10 μM, 50 μM, 200 μM, 800 μM glucose. 
(note: the sensor was rinsed with water and soaked briefly in PBS buffer between each placement in 
capillary tube containing the test interferent or standard.)  (b) Resulting calibration curve of tear glucose 
sensor. Error bars represent s.d. of n=3 replicate measurements of each standard within capillary tubes. 
 
2.3.3 In Vitro Performance of Tear Glucose Sensor 
Our group has previously reported data regarding a tear glucose detection system 
based on a needle-type amperometric electrode coupled with a glass micro-capillary 
configuration.
11
  Such a miniature sensor is able to be inserted into a micro-capillary that 
holds microliter volumes of tear samples.  In this earlier work, within 5 min, 5 µL of 
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rabbit tear fluid was carefully pulled into the capillary tube from the meniscus of the 
lower eyelids without inflicting any damage to the eye.  The results showed a significant 
correlation between tear and blood glucose levels at the higher end range (7 mM -18 
mM) in an anesthetized rabbit model, with variable correlation ratios for each individual 
animal.   
It is known that anesthesia will cause an increase of blood glucose 
concentrations
12
 by initially elevating blood glucose levels that continuously taper over 
an 8 h test period to levels that are slightly higher than normal (7-8 mM).  For the present 
study, with a newly modified animal protocol, insulin was administrated into the rabbit’s 
jugular vein to lower the elevated blood glucose levels 1 h after anesthesia was initiated.  
The use of insulin in the new animal model enabled us to examine whether a similar 
correlation exists between tear glucose and blood glucose cocentrations in this animal 
model at more normal and even hypoglycemic blood glucose levels.  Figure 2.6 shows 
results from a pilot experiment with continuous infusion of insulin (4 U/mL in saline) 
into the rabbit ear vein for 75 min.  The blood glucose dropped from an initial value of 
10.4 mM (187.2 mg/dL) to 7.6 mM (136.8 mg/dL) in 30 min, and then gradually 
decreased to 0.6 mM (10.8 mg/dL) at the end of the 7 h experiment.  Two separate 
coulometric sensors (Figure 2.6 a and b) were employed to measure glucose levels in 
rabbit’s tear fluid.  Both sensors were able to detect the very low corresponding glucose 
levels in tear fluid, which shared the same decreasing trend as the blood glucose, 
indicating that blood and tear glucose levels do indeed change in tandem over this wide 
concentration range.  A linear least-square regression was obtained for the measured 
glucose levels in tears and blood samples for this pilot experiment.  A strong Pearson’s 
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correlation was observed with a determined r
2
=0.9309 and 0.8302 (p<<0.05) for two 
separate coulometric sensors, as shown in Figure 2.6. 
 
 
Figure 2.6.  Tear and blood glucose level correlation results from one rabbit measured by two separate 
coulometric sensors a) and b) under a modified wide blood glucose range protocol. 
 
However, since it is difficult for the animal to survive the surgery at the extreme 
hypoglycemic levels (< 3 mM) for a long time period, the initial insulin protocol was 
modified to provide an insulin bolus into the rabbit vein instead of the continuous 
infusion.  The concentration of insulin was also decreased to one-tenth of the original 
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value, to 0.4 U/mL.   In this way, the blood glucose drops from initial values in the range 
of 12-18 mM (216-324 mg/dL) to the range of 5-9 mM (90-162 mg/dL) in 30 min, and 
then gradually decrease to 2-3 mM (36-54 mg/dL) at the end of a 7 h experiment.  A 
representative result from one rabbit using this optimal protocol is shown in Figure 2.7.   
 
Figure 2.7.  Tear and blood glucose level correlation results from one rabbit measured by (a) amperometric 
and (b) coulometric  sensors under the optimized wide blood glucose range protocol.  (Note: amperometric 




The rabbit was first left under anesthesia without insulin so as to collect samples 
at high glucose levels for 1 h.  Then, one injection (0.4 mL) of the insulin solution was 
administrated, and the blood glucose dropped from 9.0 mM to 5.1 mM within 30 min, 
followed by the lowest point at 2.2 mM after 90 min.  The Pearson’s correlation analysis 
reveals a significant relationship between tear and blood glucose concentrations 
(r
2
=0.8956, p<<0.05) and a linear regression shows a good fit of the data.  In addition to 
the strong correlation across a wide glucose concentration range, the tear glucose levels 
(50-150 µM) measured by both amperometric and coulometric sensors at the normal 
blood glucose range (5-8 mM) are consistent with the most recent reports in the 
literature.
15
  Separate correlation ratios are still observed in the modified animal protocol 
for different rabbit subjects, indicating the likely necessity of pre-calibrating the tear-
blood ratio for each individual in potential real-world applications.   
It is also important to note that tear glucose concentration from the left and right 
eye of the same rabbit subject (even with the same amperometric or coulometric sensors 
used) was quite different mainly due to different rates of tear production in each eye 
during the 7 h of anesthesia.  This difference in tear glucose levels in each eye of the 
animals was frequently observed in these studies, despite the fact that rabbit was rested in 
a prone position to facilitate the tear drainage as much as possible.  Indeed, visually it 
was easy to observe that several rabbits still preserved more tear fluid in one eye than the 
other.  In Figure 2.8, tear fluid collected from left and right eyes of the same rabbit 
individual and measured with two coulometric sensors (of similar selectivity and 




Figure 2.8.  Tear and blood glucose level correlation results from one rabbit sampled from left eye (dot) 
and right eye (square) using coulometric sensors under the optimized wide blood glucose range protocol. 
 
2.3.4 Correlation of Tear and Blood Glucose from Rabbit Model 
The correlation between tear and glucose concentration has been investigated in a  
previous study using the amperometric sensor design.
11
  Figures 2.9 and 2.10 show tear 
and blood glucose data from 6 rabbits under the optimal protocol used in this study for 
both the amperometric and coulometric sensor measurements.  Though the measured tear 
glucose levels and blood glucose concentrations for individual rabbits clearly correlated 
(Figure 2.6 and 2.7), the total data set is widely dispersed (Figure 2.9a and 2.10a).  This is 
mainly due to the individual difference (rabbit weight, initial glucose concentration, tear 
production rates in different eyes, etc.) from rabbit to rabbit, and thus the overall trend 
between tear and blood glucose level is undermined and could hardly be observed.  
Moreover, with the administration of insulin, each rabbit responded differently in time to 
the insulin to lower the blood glucose concentrations.  Indeed, the exact number of 
boluses of insulin required to reach a normal or hypoglycemic levels of blood glucose 
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varied from animal to animal.  Therefore, simply taking the average of all glucose 
concentrations for 6 rabbits at each measuring time point (30 min) to obtain a general 
trend is not applicable here.   
 
Figure 2.9. Amperometric results of correlation between tear and blood glucose levels using a rabbit model: 
a) All the data points of tear and blood glucose values of the total 6 rabbits.  (b) The average values of both 
tear and blood glucose levels for all animals in study at every half hour time point fitted to least-squares 




Figure 2.10.  Coulometric results of correlation between tear and blood glucose levels using a rabbit model: 
a) All the data points of tear and blood glucose values of the total 6 rabbits.  (b) The average values of both 
tear and blood glucose levels for all animals in study at every half hour time point fitted to a least-squares 
linear regression.   
 
In order to draw a clearer conclusion of the global tear-blood glucose correlation, 
a simple normalization model can be used.  For each data point (tear or blood glucose 
concentration) of sample i (i=1, 2, 3, …12) in experiment j (j=1, 2, 3,…6), we normalized 
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the concentration by dividing by the mean glucose levels (over the entire 7 h experiment) 
for each animal (   
  
   
 
 
∑     
), a standard score method with minimum effect on data.
16
  
For a    
   , it simply means that the measured glucose level is lower than the mean 
values of the rabbits, and a    
    indicates a higher than the mean glucose 
concentration. 
Further, for each rabbit, the tear glucose concentrations were first paired with the 
corresponding blood glucose values that were measured at the same time point. Then the 
blood glucose concentrations were sorted and listed horizontally in Figures 2.9b and 
2.10b.  The x value of each data point is the average concentrations of blood glucose of 6 
rabbits (  ̅  
 
 
∑    
 
           ).  Similarly, the average tear glucose concentration 
of 6 rabbits crossing different experiments is presented as the y value data point.  Error 
bars represent one standard deviation for 6 rabbits at the given glucose concentrations.  
Therefore, these error bars depict the individual glucose concentration variations for 
different animals, rather than representing the precision of the measurement itself. 
For the normalized data shown in Figures 2.9b and 2.10b, the final linear 
regression models reveal a significant correlation between tear and blood glucose 
concentrations with the determined R square values (                  for 
amperometric sensor, and  2=0.8255     0.05  for coulometric sensor), indicating a 
reasonable linear relationship between measured tear and blood glucose levels.  Clearly, 
it can be concluded that the tear glucose concentration does change in tandem with the 
blood glucose concentration, and the shared trend shows a good fitting to a simple linear 
regression model.  However, separate correlation ratios are still observed in the modified 
56 
 
animal protocol for different rabbit subjects, indicating the necessity to ultimately pre-
calibrate the tear-blood correlation for each individual in potential real-world applications. 
 
2.3.5 Clarke Error Grid Analysis 
Further, the gold standard Clarke error grid analysis
17, 18
 can also be applied to 
evaluate the clinical accuracy of predicting blood glucose levels from electrochemical 
tear glucose measurements.  First, the blood glucose values are calculated from the tear 
glucose concentrations that were sampled at the same time point based on the individual 
tear-blood correlation ratio (i.e., the slope from the tear-blood glucose concentration plot).  
The values were converted to mg/dl from mM in order to be plotted using the typical 
Clarke error grid analysis.  These blood glucose values are plotted as the predicted blood 
concentrations on the y-axis, and the actual plasma glucose values that are measured 
directly by a Radiometer whole blood analyzer are plotted as the reference concentrations 
on the x-axis.  In Figure 3.11a, the blood glucose concentrations predicted from the 
amperometric tear glucose measurements are plotted along with the reference values, and 
91.7% of the results fall into the clinically acceptable zones A and B, strongly suggesting 
that the amperometric tear glucose measurement can provide a supplementary tool to 
monitor blood glucose levels with good clinical accuracy.  For the coulometric sensor, 
results plotted via the Clarke error grid analysis method indicate that 84.3% of the 
predicted blood glucose values fall within zones A and B (Figure 3.11b.).  Since the 
coulometric sensors utilized here were not fully optimized to consume all glucose in the 
tear test samples during the 5 min measurement period, it is likely that the lower % of 
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values in zones A and B vs. the amperometric sensor system, may reflect some variations 
in the kinetics of glucose consumption between different µL volumes of tear samples, 
relative to the consumption kinetics observed in the µL volumes of glucose calibration 
solutions. 
 
Figure 2.11. Clarke error grid analysis for evaluation of blood glucose values determined from the tear 
glucose concentrations measured by a) amperometric (Zone A= 48.61%, Zone B= 43.06%, Zone C= 4.17%, 
Zone D= 2.78%, Zone E= 1.39%) sensor and b) coulometric (Zone A=44.29%, Zone B= 40%, Zone 
C=10%, Zone D=5.71%) sensors in 6 rabbits. 
 
2.4 Conclusions 
We have developed simple electrochemical tear glucose biosensors based on 
amperometric or coulometric measurement methods coupled with a fluid collection glass 
micro-capillary configuration.  These electrochemical sensors were employed in 
anesthetized rabbit experiments to detect tear glucose levels over a wide concentration 
range of blood glucose values.  With the optimized administration of insulin, a clear 
correlation between tear and blood glucose levels was obtained over a wide range of 




varies from animal to animal and the correlation ratio differs.  This suggests that the ratio 
between blood and tear glucose varies significantly from animal to animal.  Therefore, to 
use tear fluid as an alternate sample to evaluate blood glucose for human subjects, the 
approach will likely require a pre-calibration step to obtain the exact ratio between blood 
and tears glucose for each individual.  Once this correlation is established for a given eye, 
the proper algorithm can be employed for the reported tear glucose results in order to 
reflect a corresponding value of blood glucose.  With further improvements in its design, 
the new coulometric sensor, which measures the total charge resulting from total 
depletion of glucose from the sample tear volume, will likely enable more precise 
detection of glucose at much lower concentrations.  This may not require any sensor pre-
calibration, provided a reproducible and constant volume of tear fluid can be collected 
and that all the glucose present is consumed in the time course of the measurement.  
Efforts to utilize this new design with an even much smaller sample volume (< 1 μL) to 
measure the concentrations of glucose in human tear fluid is a future direction for this 




1. Y. Ohashi, M. Dogru, and K. Tsubota, Clinica Chimica Acta, 2006, 369, 17-28. 
2. D.K. Sen and G.S. Sarin, Br. J. Ophthalomol., 1980, 64, 693. 
3. J. LeBlanc, C. Haas, G. Vicente, and L. Colon, Intens. Care Med., 2005, 31, 
1442-1445. 
4. J.T. Baca, D.N. Finegold, and S.A. Asher, Ocul. Surf., 2007, 5, 280-293. 
5. A. Tomlinson and S. Khanal, The Ocular Surface, 2005, 3, 81-95. 
6. A. Romano and F. Rolant, Metab. Pediatr. Syst. Ophthalmol., 1988, 11, 78-80. 
7. J.D. Lane, D.M. Krumholz, R.A. Sack, and C. Morris, Curr. Eye Res., 2006, 31, 
895-901. 
8. R. Chen, Z. Jin, and L.A. Colon, J. Cap. Elec., 1996, 3, 243. 
9. W.F. March, A. Mueller, and P. Herbrechtsmeier, Diabetes Technol. Ther., 2004, 
6, 782-789. 
10. H. Yao, A.J. Shum, M. Cowan, I. Lähdesmäki, and B.A. Parviz, Biosens. 
Bioelectron., 2011, 26, 3290-3296. 
11. Q. Yan, B. Peng, G. Su, B.E. Cohan, T.C. Major, and M.E. Meyerhoff, Anal. 
Chem., 2011, 83, 8341. 
12. J.K. Saha, J. Xia, J.M. Gorndin, S.K. Engle, and J.A. Jakubowsku, Exp. Biol. 
Med., 2005, 230, 777. 
13. C.K.M. Choy, I.F.F. Benzie, and P. Cho, Investigative Ophthalmology & Visual 
Science, 2000, 41, 3293-3298. 
14. Q. Yan, T.C. Major, R.H. Bartlett, and M.E. Meyerhoff, Biosens. Bioelectron., 
2011, 26, 4276. 
15. M.X. Chu, T. Shirai, D. Takahashi, T. Arakawa, H. Kudo, K. Sano, S. Sawada, K. 
Yano, Y. Iwasaki, K. Akiyoshi, M. Mochizuki, and K. Mitsubayashi, Biomed. 
Microdevices, 2011, 13, 603-611. 
16. Y. Dodge, ed. The Oxford Dictionary of Statistical Terms. 2006, Oxford 
University Press, USA; 6 edition (September 7, 2006). 
17. W.L. Clarke, D. Cox, L.A. Gonderfrederick, W. Carter, and S.L. Pohl, Diabetes 
Care, 1987, 10, 622-628. 
60 
 
18. B.P. Kovatchev, L.A. Gonder-Frederick, D.J. Cox, and W.L. Clarke, Diabetes 










3. 1. Introduction 
Nitrix oxide (NO), the elusive endothelial-derived relaxing factor (EDRF), is well 
recognized for playing critical roles in platelet inhibition, vasodilation, and wound 
healing.
1-3
  However, NO does not exist to any significant degree in blood due to its rapid 
reaction with oxyhemoglobin to form methemoglobin and nitrate.
3
  Therefore, the 
therapeutic delivery of localized NO on demand in biological system has been a very 
challenging task. 







) can be released from polymeric materials by incorporating NO donors 
(diazeniumdiolates or S-nitrosothiols) within the matrices.
4-7
  The kinetics of NO release 
from such materials can be modulated by changing the polymer matrix or the structure of 
the NO donor.  Other methods of preparing NO-releasing polymers consisting of small-
molecule RSNOs donors, such as S-nitroso-N-acetyl-L-cysteine (SNAC) and S-





 groups.  The NO delivery for these systems was accomplished by 
thermal, photochemical, or catalyst (copper ion, Cu
+
) activation.      
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Our research interest focuses on employing a novel electrochemical method to 
modulate NO release from donors. This new design can provide a potential alternate 
method to realize quantitative NO release in a controlled manner.  Indeed, it can be 
achieved by using either electrochemically active NO donor compounds (which can be 
electrochemically reduced or oxidized to give NO) or proton driven NO precursors (e.g., 
nitrite salts, diazeniumdiolates).  In particular, S-nitrosothiols (RSNOs) are potent donors 
of NO and can release localized transient levels of NO under physiological conditions via 
various decomposition pathways (thermal, photolysis, catalytic metal ion reduction, 
etc.).
10
  The S-NO group decomposes rapidly upon a one-electron reduction in vivo, and 
therefore provides a selective means to release NO from RSNOs in physiological systems.  
This reduction reaction can be catalyzed by Cu(I/II) or organoselenium species, such as 
proteins that contain Cu(I/II) centers or selenocysteine groups.
11
 
Based on the known one-electron reduction chemical reactions that can liberate 
NO from RSNOs in solution, it was thought that electrochemical reduction of RSNOs 
could provide a potential alternate approach to realize quantitative NO release in a 
controlled manner.  In fact, it has been reported previously that RSNOs can undergo a 
one-electron reduction and release NO on glassy carbon or hanging mercury drop 
electrodes at physiological pH.
12-14
  Controlled potential electrolysis suggested that NO 
was released at cathodic potentials.
15
  However, in these prior studies, the conclusion that 
NO was a product upon electrochemical reduction of RSNOs was based solely on cyclic 
voltammetry in which following reduction, sweeping to more positive working electrode 
potentials yielded an oxidation peak that corresponded to the potential where NO is 
typically oxidized.  This previous research inspired us to consider a new method to create 
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NO releasing materials.  By tuning the applied reduction potential via an electrode within 
a matrix with embedded RSNOs, a novel approach for creating voltage-triggered NO 
release materials could ultimately be developed.  This type of control would allow 
fundamental studies to define necessary NO fluxes required to achieve specific 
therapeutic effects.  Moreover, the use of a voltage trigger to initiate release provides a 
method of temporal control of the NO flux.   
Toward this goal, preliminary studies were conducted to verify that both 
physiological (S-nitrosoglutathione (GSNO), S-nitrosocysteine (CysNO)) and synthetic 
RSNOs (S-nitroso-N-acetyl-DL-penicillamine (SNAP), S-nitroso-N-acetyl-L-cysteine 
(SNAC)) can be electrochemically reduced.  However, during these studies, no evidence 
of NO gas production could be found at pH 7.4, indicating that NO is not necessarily the 
predominant reductive product, or a multiple-step electrochemical reaction, rather than a 
simple one-electron transfer, is involved in the electrolysis.  All previous studies reported 
in the literature were carried out at pH 7.4, given that endogenous S-nitrosoglutathione 
would exist at this physiological pH.  However, preliminary studies regarding the effect 
of pH on the electrochemical reductive pathway of RSNOs were also carried out in this 
thesis work at different pH 4.0 and 10, and it is reported here, for the first time, that pH is 
critically important to the electrochemical redution products formed from RSNO species.  
Indeed, to better understand the reaction and provide critical information to assess the 
potential application of using the electrochemistry of RSNOs in creating new 
electrochemical NO releasing devices, it is important to characterize the electrochemical 
decomposition path and sort out the actual reductive products.  Hence, results from 
detailed solution and gas phase analysis via both electrochemical and spectroscopic 
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methods are presented in this chapter regarding the electrochemical reduction of S-
nitrosothiols. 
3.2. Materials and Methods  
3.2.1 Materials 
Glutathione (GSH), cysteine (Cys), N-acetyl-L-cysteine (NAC), S-nitroso-N-
acetyl-DL- penicillamine (SNAP), ethylenediamine tetraacetic acid (EDTA), N-(1-
naphthyl)ethylene diamine dihydrochloride (NED), sodium acetate, potassium phthalate 
obtained from Sigma-Aldrich (Milwaukee, WI) and sulfanilamide from Acros (Morris 
Plains, NJ) were used without further purification unless otherwise noted.  A standard 
NO(g) stock solution was prepared from deoxygenated acidified nitrite solution. The 
generated gas was bubbled through 20% (wt%) NaOH solution to remove any 
interference nitrogen dioxide species and then collected in deoxygenated DI water for 30 
min.   Via use of a nitric oxide analyzer (NOA) (Seivers 280, Boulder, CO), the 
concentration of NO in a saturated solution was determined to be 1.9 mM at 25 C and 
PNO=1 atm.  S-Nitrosoglutathione (GSNO), S-nitrosocysteine (CysNO), and S-nitroso-N-
acetyl-L-cysteine (SNAC) were synthesized by nitrosating the sulfhydryl groups of the 
corresponding thiols (GSH, CySH, and NAC) in acidified nitrite solution, as reported in 
the literature.
16
  The formation of the S-nitroso group was confirmed by a characteristic 
absorption at 335 nm via UV-Vis spectrophotometry.  Phosphate buffered saline (PBS) 
and all other solutions were prepared with 18.2 MΩ·cm
-1
 DI water from a Milli-Q system 
(Millipore Corp., Billerica, MA). 
3.2.2 Electrochemical Reduction of RSNO 
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The RSNOs stock solutions (5 mM) were directly injected into a working buffer 
solution (PBS, 10 mM, pH 7.4) containing 0.1 mM EDTA (necessary to suppress metal 
ion impurities and prevent catalytic RSNO decomposition, especially from copper ions) 
to obtain the desired concentrations.  All RSNO measurements were carried out in amber 
cells to avoid photolytic decay.  A potentiostat (CHI 800B, Austin, TX) was used to 
examine the electrochemistry of RSNOs via cyclic voltammetry and chronoamperometry 
techniques.  Preliminary cyclic voltammetry experiments of four different RSNOs 
(GSNO, CysNO, SNAC, SNAP) were tested on both polycrystalline gold and glassy 
carbon electrode surfaces (3 mm in diameter, CHI, Austin, TX) in 1 mM RSNO solutions 
prepared in deoxygenated PBS.  GSNO was then selected as the model molecule for all 
other electrochemical reduction reactions studies due to its good stability (up to a few 
hours) and physiological abundance.  Typically, a solution of 2 mM GSNO in stirred PBS 
was reduced at a potential of -0.8 V (vs. Ag/AgCl) on a Au mesh or glassy carbon 
electrode for 1 h, using a platinum coil behind a glass frit as the counter electrode.  
Before all electrochemical reactions, the cell was purged with either nitrogen or argon to 
prevent the oxidation of end products from any dissolved and headspace oxygen present.   
3.2.3 Detection of NO 
To assess whether NO is liberated during the electrochemical reduction of RSNOs, 
the reaction solution was constantly purged with N2(g) and the gas phase stream was 
monitored by a highly sensitive and selective chemiluminescence nitric oxide analyzer 
(NOA).   An amber combination Echem-NOA cell (10 mL, Figure 3.1) was specially 





Figure 3.1. Schematic representation of the Echem-NOA cell set-up. 
 
3.2.4 Detection of NO2
- 
The colorimetric Griess assay was conducted to measure nitrite (NO2
-
) produced 
from NO after RSNO reduction.  A mixture of 15 mM sulfanilamide and 0.23 mM NED 
in 0.75 M HCl was prepared as the Griess reagent.  Prior to sample measurement, the 
response of the Griess reagent towards a series of standard nitrite solutions was 
monitored by a UV-Vis spectrophotometer (Lambda 35, Perkin-Elmer, MA).  The strong 
absorbance at a λmax of 540 nm was plotted against NO2
-
 concentrations to obtain the 
calibration curve.  A 500 µL aliquot of the RSNO reduction solution was injected into a 
cuvette with 500 µL of Griess reagent and kept on the bench for 10 min to fully mix and 




3.2.5 Detection of Ammonia (NH3) 
Potentiometric measurement of ammonia was employed to evaluate whether NH3 
is one of the electrochemical reduction products of RSNOs.  A high performance NH3 
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gas sensor (Thermo Scientific, Beverly, MA) was used to measure the concentration of 
dissolved ammonia gas in GSNO solutions after electrochemical reduction.  The sensor 
was mounted with Teflon gas-permeable membrane and preconditioned in 0.1 M NH4Cl 
solutions overnight and then in 15 μM NH4Cl for 30 min prior to use.   Small aliquots of 
1 mM NH4Cl solution were first added into a 0.2 M NaOH solution to calibrate the 




 M) range.  A 2 mL sample solution of 
electrochemically reduced GSNO (reduction for 30 min at gold mesh electrode) was then 
introduced to a fresh 2 mL NaOH solution with a 1:1 dilution for measurement of 
ammonia in the electrolyzed GSNO solution.  
3.2.6 Detection of NO
-
/N2O 
Gas phase FT-IR spectroscopy (Spectrum BX, Perkin-Elmer, MA) was utilized to 
verify the existence of N2O that would be produced from NO
-
 after GSNO decomposition.  
An amber electrochemical cell (50 mL) was aligned with a CaF2 windowed (Pike Tech., 
Madison, WI) IR gas cell to collect the headspace gas from a GSNO solution after 
electrochemical reduction for 60 min at gold mesh electrode.  Because of the high 
reactivity of N2O with O2, the GSNO solution was first purged with argon for 30 min 
prior to reaction and the IR gas cell was evacuated by vacuum before collecting the 
reductive headspace gas.  
 
3.3. Results and Discussion 
3.3.1 Preliminary Studies on the Electrochemical Reduction of RSNOs 
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For preliminary studies, cyclic voltammetric experiments were carried out for 
both physiological (GSNO, CysNO) and synthetic (SNAC, SNAP) RSNO species at 
polycrystalline gold and glassy carbon electrodes.  As shown in Figure 3.2, the various 
RSNOs at 1 mM concentrations can be electrochemically reduced, exhibiting an 
irreversible cathodic wave at a potential of -0.8 V (vs. Ag/AgCl) on gold electrode 
surface at pH 7.4.  The reduction of 1 mM NO(g) is overlaid as trace b in Figure 3.2, 
showing a different voltammogram pattern where the cathodic current starts increasing 
from -0.8 V and does not yet give a clear reductive peak even at -1.0 V.  Therefore, it can 
be concluded that the observed cathodic peaks for the RSNO solutions are not due to the 
reduction of dissolved NO originating from RSNO self-decomposition (thermal, photo, 
etc.).  Rather the reduction peak must be due to direct electrochemical reduction of the S-
nitroso bond.  
 
Figure 3.2. Cyclic voltammgrams of 1 mM NO and RSNOs in 10 mM PBS on a gold electrode at a scan 




The reduction peaks for RSNOs appear as totally irreversible waves in which the 
observed peak potential (Ep) is a function of scan rate, shifting in a negative direction 
with the increase in scan rate (υ) (Figure 3.3).  This irreversible behavior suggests that the 
S-nitroso bond of GSNO has been electrochemically cleaved and can no longer be 
oxidized back on the electrode surface.  Furthermore, plotting the peak current (ip) versus 
the square root of scan rate (υ
1/2
) shows that ip is proportional to υ
1/2
, indicating a 




Figure 3.3. Cyclic voltammograms of 1 mM GSNO in 10 mM PBS on gold electrode at different scan rates 
(V/s) a to e: 0.02, 0.04, 0.06, 0.08, 0.10 V/s; inset: ip versus υ
1/2 fit into a linear regression. 
 
Very similar data to that shown in Figures 3.2 and 3.3 above, are obtained when 
using a glassy carbon electrode as the working electrode for reduction of RSNOs (Figure 
3.4).  This suggests that the electrochemical reduction of RSNOs occurs by similar 




Figure 3.4. Cyclic voltammgrams of 1 mM RSNOs in 10 mM PBS on a glassy carbon electrode at a scan 
rate of 0.05 V/s (vs. Ag/AgCl), a: blank PBS; b: GSNO; c: SNAC; d: CysNO. 
 
3.3.2 NO Produced from RSNOs  
Chemiluminescence Detection 
To further investigate the electrochemical reaction, a highly sensitive 
chemiluminescence nitric oxide analyzer (NOA) was used to assess whether NO is in fact 
liberated upon the electrochemical reduction of the S-nitroso bond of RSNOs.  The 
generated NO can undergo a rapid reaction in the gas phase with ozone, yielding nitrogen 
dioxide (NO2) in an excited state.   As the excited electron returns to the ground state, a 
photon is emitted and detected as chemiluminescence.  This highly specific, sensitive and 
reliable method is considered to be the gold standard for trace level NO detection.
18
 
Surprisingly, when a cathodic potential of -0.8 V (vs. Ag/AgCl) was applied using 
a large area gold mesh working electrode (2.5 cm×3.5 cm, 100 mesh) and the solution (10 
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mM PBS, pH 7.4) was purged with nitrogen continuously (into NOA), no significant NO 
increase is observed via the NOA analyzer (Figure 3.5).  Instead, the initial NO flux 
derived from the auto-decomposition of GSNO (about 4×10
-12
 mol/sec) actually 
decreases when the cathodic potential was applied (Figure 3.5). This is likely from the 
electrochemical reduction of NO at this potential, as observed from trace b in Figure 3.2. 
This result indicates that NO is not likely the predominant product of the electrochemical 
RSNO reduction reaction at pH 7.4, or a multiple-step electrochemical reaction rather 
than a discrete one-electron transfer is involved in the reduction of RSNOs. 
 
Figure 3.5. NO profile of 10 μM GSNO during electrochemical reduction at -0.8 V (vs. Ag/AgCl) and 
open-circuit voltage (OCV) on a gold mesh electrode surface.  
 
Griess Assay for Nitrite Detection 
Besides the chemiluminescence method to detect NO, a spectrophotometric 
Griess assay was employed to measure nitrite ion formed by the possible oxidation of NO 
with oxygen.  In brief, under acidic conditions, sulfanilamide reacts with NO2
-
 to form a 
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diazonium cation that further reacts with N-(1-naphthyl)ethylenediamine, producing a 
diazo molecule characterized by a strong absorbance at 540 nm.   
This type of spectroscopic method is highly sensitive and can yield a detection 
limit as low as 1 µM.  Thus, it is an ideal tool to monitor the level of any nitrite ions 
formed in the GSNO solutions as a function of the electrochemical reduction time of 
RSNOs.  Unfortunately, when a sample of 1 mM GSNO solution was electrolyzed (at -
0.8 V for 60 min at gold mesh electrode) and then analyzed by this method, there was 
very little absorbance at 540 nm (< 0.25 µM equivalent nitrite, Figure 3.6), further 
suggesting that no significant amount of NO was produced from the electrochemical 




Figure 3.6. a) Response curves (dashed lines) towards concentrations (0.25, 0.50, 0.75, 1.00, 1.50, 2.00 μM) 
of NaNO2, and the addition of SNAP samples under different periods of echem reduction on a gold mesh 








3.3.3 Possible Reductive Products of RSNOs 
Since all previous reports state that NO is the predominant reductive product from 
the electrochemical reduction of RSNOs at physiological pH,
12-14
 the data shown in 
Figure 3.5 are rather surprising. Although most decomposition pathways of RSNOs 
mainly lead to the homolytic cleavage of the S-NO bond and formation of the NO free 
radical, these pathways may not be exclusive because the chemistry of these compounds 
is complex.  Indeed, there are several possible candidates besides NO, such as ammonia 
gas, nitrosonium ions, and nitrosyl ions that may be produced.   
Ammonia (NH3) 
Ammonia has been reported as one of the end products of the redox reaction 
between RSNO and high levels of a given thiol.
19
 Therefore, we investigated whether 
direct electron transfer via an electrochemical method can also lead to the formation of 
ammonia in the RSNO solution that undergoes electrolysis at -0.8 V. 
Severinghaus-type NH3 electrodes are based on a gas-permeable membrane that 
separates the sample from an internal solution in which a glass electrode monitors the 
pH.
20
  These devices are used to reliably measure dissolved ammonia and ammonium 
ions by adding base to convert ammonium to ammonia gas. Such electrodes have been 
approved by the United States Environmental Protection Agency (EPA) and are also 
described as a standard method for ammonia detection.
21
 
Indeed, the ammonia electrode exhibits a fast response and wide dynamic range 
from 10
-6
 M to 10
-2
 M towards ammonia (Figure 3.7a), providing an excellent analytical 
tool to measure ammonia produced due to the electrochemical reduction of GSNO at a 
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large area gold mesh electrode.  However, as shown in Figure 3.7b, after reduction of 2 
mM GSNO for 30 min with stirring at pH 7.4, there is no immediate ammonia sensor 
response upon the addition of a sample of the GSNO solutions, except for a slow drift 
that is mostly due to accumulation of dissolved ambient ammonia.  Moreover, there was 
no significant difference between samples that were blank PBS and ones that underwent 
30 min of cathodic reduction, indicating no appreciable amount of ammonia is produced 






Figure 3.7. a) Response and calibration (inset) curves towards concentrations (10-6 to 10-2 M) of NH3, 
exhibit a sub-Nerstian response with a slope of -53.7 mV/decade. b) EMF response with the addition of 





As previously reported, RSNOs can also react with thiols and produce NO
-
, which 





  More specifically, NO
-
 can be an active intermediate that will undergo a fast 
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under anaerobic conditions, 
or react with oxygen to form OONO
-
 under aerobic condition.
23
  The existence of NO
-
 is 
inferred by the detection of N2O since it has an advantage of being infrared active with 










Therefore, anaerobic headspace gas analysis was conducted to elucidate whether 
NO
-
/N2O is a reduction product from the electrochemical reaction of RSNOs at pH 7.4.  
Beforehand, a 2 mM solution of saturated NO in 100 mM PBS was reduced at a potential 
of -0.8 V (vs. Ag/AgCl) on the Au mesh electrode for 1 h.  The gas phase FT-IR 
spectrum of the headspace gas shown in Figure 3.8 confirms the presence of N2O at 
wavenumbers 2211 cm
-1
 and 2235 cm
-1
, strongly indicating that N2O is a reductive 
product of NO (stretching bands at 1790 and 1810 cm
-1
) at -0.8 V on a Au surface.  
Another identifiable absorbance band at a lower wavenumber of 1630 cm
-1
 is probably 
due to trace amounts of NO2 present.  Most importantly, when a solution of 2 mM GSNO 
in 100 mM PBS (pH 7.4) undergoes the same electrochemical reduction on either Au or 
glassy carbon electrodes, bands at 2211 cm
-1
 and 2235 cm
-1 
appear to prove that N2O is 





Figure 3.8. FT-IR spectrum of headspace gas from deoxygenated 2 mM NO in 100 mM PBS (pH 7.4), 
after reduction at -0.8 V (vs. Ag/AgCl) on Au mesh electrode for 1 h. 
 
 
Figure 3.9. FT-IR spectrum of headspace gas from deoxygenated 2 mM GSNO in 100 mM PBS (pH 7.4), 
after reduction at -0.8 V (vs. Ag/AgCl) on Au mesh electrode for 1 h. 
 
Moreover, a series of pulsed reduction potentials (between -0.6 V to -0.9 V) were 
applied to a gold mesh electrode in the presence of 100 μM GSNO in PBS solution at pH 
7.4.  The NOA results shown in Figure 3.10 exhibit an interesting “up-and-down” pattern 
when the applied voltage is switched between anodic (0 V) and cathodic potentials.  The 
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reducing potentials result in an immediate NO decrease, and switching back to the 
oxidizing potential (0 V) leads to an increase of NO concentration.  These results suggest 
that at pH 7.4 under reduction potentials between -0.6 V to -0.9 V, any NO that results 
from GSNO is further reduced into another reductive product, which can then be oxidized 
back to NO at a more anodic potential.   
 
Figure 3.10. Nitric oxide profile of 10 μM GSNO in 100 mM PBS (pH 7.4), first in absence of any 
potential application, and then after different potentials are applied to gold mesh electrode. 
 
Indeed, two possible reductive pathways may occur upon the electrochemical 
reduction of RSNOs (see Scheme 3.1 below) at pH 7.4.  A one-electron transfer reaction 
(to form transient NO, Eq. 3.1) followed by an immediate second electron transfer (Eq. 
3.2) to create N2O (Eq. 3.4) is one possibility.  Another option is a direct one-electron 
transfer process to two RSNOs molecules that will also produce N2O via a nitrosyl 
intermediate (Eq. 3.3, 3.4). 
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Scheme 3.1. Proposed reactions for the electrochemical reduction of RSNOs. 
To calculate the number of electrons transferred in the reactions, UV-Vis 
spectroscopy was utilized to quantitatively monitor the amount of RSNOs remaining in 
solution after bulk electrolysis of GSNO at -0.8 V.  The characteristic absorbance of S-
NO at 335 nm was detected before and after GSNO was reduced. With a molar extinction 




, the amounts of consumed GSNO after one hour of 
reduction was 5.94×10
-6
 mole. At the same time, the total charge passed through the 
electrochemical reaction was 1.83 coulombs, which was produced by 1.90×10
-5
 moles of 
electrons. Based on these results, an estimated number of electrons transferred is 3.2 per 
reaction.  Clearly, this does not agree with either of the one-electron or two-electron 
transfer reactions suggested above.  This could be explained by the many possible side 
reactions that can occur at the same time and would result in a more than the expected 
number of electrons.  For example, one possibility is the reaction between HNO 
(produced by protonation of NO
-
) and free thiols in solution, to further reduce HNO and 
produce hydroxylamine (NH2OH) and a disulfide.  A two electron reduction of the 
disulfide could occur at the reductive potentials applied in the above experiments, 
increasing the number of electrons observed under coulometric conditions.  In theory, 
hydroxylamine can also be reduced, but the product of this electrochemical reduction 
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reaction is usually ammonia,
25
 and hence there is no evidence that hydroxylamine, if 
formed, is also being reduced electrochemically at the potentials applied.  In contrast, it is 
known that alkyl disulfides can be reduced in the range of -0.8 V to -1.0 V on gold 
electrode,
26
 and hence the presence of significant levels of these species could explain the 
coulometry results.  
 
3.3.4  pH Effect on Electrochemical Reduction of RSNO 
All previous studies reported in the literature, as well as those described above 
were carried out at pH 7.4, given that endogenous S-nitrosoglutathione would exist at this 
physiological pH.  However, preliminary studies regarding the effect of pH on the 
electrochemical reductive pathway of RSNOs were also carried out at pH 4.0 and 10.  
Figure 3.11 shows the cyclic voltammgrams of GSNO on gold disk electrode in pH 4.0 
PBS at different scan rates.  The negative shift at higher scan rate suggests an irreversible 
reduction of the S-nitroso bond.  The cathodic peak potentials are similar to those shown 
in Figures 3.2 and 3.3, with only 50 mV more positive peak voltage occurring at pH 4.0 




Figure 3.11. Cyclic voltammgrams of 1 mM GSNO in 100 mM PBS (pH 4.0) on gold electrode at different 
scan rates (V/s): 0.02 (solid line), 0.05 (dashed line), 0.08 (dotted line) V/s.  
 
Most interesting, however, is that in a solution of 10 µM GSNO in 100 mM PBS 
at pH 4.0, when a cathodic potential of -0.8 V (vs. Ag/AgCl) is applied using a large area 
gold mesh working electrode (2.5 cm × 3.5 cm, 100 mesh) and the solution is purged 
with nitrogen continuously (into NOA), a significant NO burst is clearly observed via the 
NOA analyzer (Figure 3.12).  Using a 5 min interval between application of -0.8 V and 0 
V to the gold mesh electrode, an “on” and “off” pattern of NO release is observed.  More 
importantly, by switching the potential on and off repeatedly, 97% of the total GSNO is 




Figure 3.12. Nitric oxide profile of 10 μM GSNO in 100 mM PBS at pH 4.0, first in absence of any 
potential application, and then after cathodic potentials of -0.8 V and resting potentials of 0 V (vs. Ag/AgCl) 
are alternately applied to gold mesh electrode. 
 
SNAP Species 
The results for NO release experiments at pH 4.0 are clearly very different than 
observed at pH 7.4. To assess whether this difference carries over to other RSNO species, 
the electrochemical reduction of the synthetic SNAP (with longer half-live for up to a few 
hours at 37   at pH 4.0 in PBS was also examined.  Similar quantitative NO release was 




Figure 3.13. Nitric oxide profile of 10 μM SNAP in 100 mM PBS at pH 4.0, first in absence of any 
potential application, and then after cathodic potentials of -0.8 V and resting potentials of 0 V (vs. Ag/AgCl) 
are alternately applied to the gold mesh electrode. 
 
Buffer Effect 
In order to illuminate the decomposition mechanism of RSNOs under acidic 
conditions, a variety of buffers with different pHs were employed and compared for the 
electrochemical reduction reaction.  Due to a better stability, SNAP was selected as the 
model molecule for electrochemical reduction on a gold mesh electrode.  Phthalate (pH 
3.0, pH 4.0), acetate (pH 5.0), and phosphate (pH 6.0) buffered solutions were employed 
to examine the buffer effect (Figure 3.14).  It can be concluded that in acetate or phthalate 
buffers at pH 4 and 5, similar reductive NO release are observed when the cathodic 
potential at -0.8 V (vs. Ag/AgCl) is applied.  However, at pH 6, unpredictable NO peaks 
are found.  More specifically, as shown in Figure 3.14d, the first electrochemical pulse at 
-0.8 V did not induce any NO release.  Instead, a slight decrease of NO (from the initial 
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auto-decomposition of SNAP) is observed, followed by an NO increase at 0 V.  This is 
similar to the reduction pattern as found at higher neutral pH.  Later, a second application 
of -0.8 V is able to successfully generate NO from the solution.  Indeed, at pH 6, two 
different mechanisms of the electrochemical reduction of RSNO appear to exist at the 
same time.  Therefore, pH 6 is not an ideal condition for controlled electrochemical 
reaction.  Instead, both the phthalate and acetate buffers at pH 4.0 provide a suitable 
condition for the well-modulated NO release pattern from the SNAP molecule. 
 
 
Figure 3.14. Nitric oxide profile of 10 μM SNAP in 100mM different buffers: a) phthalate buffer (pH 3.0), 
b) phthalate buffer (pH 4.0), c) acetate buffer (pH 5.0), d) phosphate buffer (pH 6.0), first in absence of any 
potential application, and then after cathodic potentials of -0.8 V and resting potentials of 0 V (vs. Ag/AgCl) 
are alternately applied to gold mesh electrode. 
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It should be noted that at more basic pH conditions, pH 10, the electrochemical 
reduction behavior is quite similar to that observed at pH 7.4 (except for a higher NO 
baseline due to poor GSNO stability at high pH), with no significant amounts of NO 
produced when cathodic potentials are applied onto gold mesh electrode (NO profile 
provided in Figure 3.15). 
 
Figure 3.15. Nitric oxide profile of 10 μM GSNO in 100 mM PBS at pH 10.0, first in absence of any 
potential application, and then after cathodic potentials of -0.8 V and resting potentials of 0 V (vs. Ag/AgCl) 
are alternately applied to gold mesh electrode. 
 
Overall, the reduction pathway of RSNOs at low pH most likely involve  a proton 
that helps favor the direct one electron reaction, with protonation of the thiolate helping 
to drive the reaction to the right in accordance with  Eq. 3.5: 





Further, as a proof-of-concept, a silicone rubber tubing based catheter was built 
for potential in vivo implantation and/or biofilm dispersion studies (Figure 3.16).  
Generally, 1 cm of gold was exposed from a Teflon coated gold wire (i.d., 76 μm) with a 
total length of 6 cm.  The gold working electrode was coiled onto a 2 cm Ag/AgCl 
electrode (i.d. 250 μm, 5 mm apparent length after coiling) and then inserted into a 2 cm 
silicone rubber tubing (i.d. 510 μm).  The polymeric tubing was sealed with silicone 
rubber glue (SR 3104, Dow Corning, MI) before and after inserting the electrodes.  A 
volume of 3 μL of the buffered RSNO solution was introduced into the silicone rubber 
tubing by a micro-syringe without any bubbles (by visual check). 
 
Figure 3.16. Schematic representation of the electrochemically modulated NO release catheter 
configuration, using gold working electrode and RSNO as the NO precursor. 
 
Based on the results shown in Figure 3.14, phthalate buffer provides a stable 
condition for the electrochemical reduction of SNAP at pH 4.  Therefore, 10 mM of 
SNAP was dissolved in 100 mM potassium phthalate buffer with 140 mM NaCl (to 
provide Cl
-
 source for the Ag/AgCl reference electrode) as the inner NO donor solution 
within the silicone rubber catheter.  A preliminary result of the catheter with the 
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electrochemically modulated NO release pattern was observed in Figure 3.17.  Similarly 
as observed in Figure 3.12, by using a 5 min interval between application of -0.8 V and 0 
V to the gold wire electrode, an “on” and “off” pattern of NO release is clearly observed 
from the catheter.  The catheter was removed at the end of the third electrochemical 
modulation cycles, and the amount of NO release decreased back to the baseline, 
indicating that no leakage of RSNO species occurred from the catheter.  
 
Figure 3.17. Nitric oxide profile of a catheter configuration filled with 10 mM SNAP in 100 mM phthalate 
buffer with 140 mM NaCl at pH 4.0, first in absence of any potential application, and then after cathodic 
potentials of -0.8 V and resting potentials of 0 V (vs. Ag/AgCl) are alternately applied to gold wire 
electrode. 
 
However, the results in Figure 3.17 indicate that the amount of NO that had been 
released during the cathodic modulations decreases with the repeated cycles.  It is further 
calculated that only 18% of total NO has been released from the 3 μL of SNAP that was 
initially filled into the 2 cm long catheter.  Therefore, a possible explanation of the 
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reduced NO release is the passivation of the gold electrode surface by the produced free 
thiol species such as N-acetylpenicillamine (from SNAP), glutathione (from GSNO), and 
cysteine (from CysNO).  A standard K3Fe(CN)6 solution was employed to examine the 
formation of self-assembled monolayer between the Au electrode surface and thiols.  In 
Figure 3.18, a clear increase of redox peak separation of the ferri/ferro-cyanide species is 
found on the Au surface after using the same electrode for SNAP reduction for 30 min 
(dotted line) and soaked afterwards overnight (solid line), indicating the existence of an 
insulating Au-thiol layer. 
 
Figure 3.18. Cyclic voltammgrams of 1 mM K3Fe(CN)6/ 0.1 M KNO3 solution on gold disk electrode that 
has been exposed to different reaction time periods in 10 μM SNAP in 100 mM phthalate buffer (pH 4.0): 
intact clean electrode before contacting SNAP solution (dashed line), after 30 min electrochemical 





Contrary to previous literature,
12-14
 results reported in this chapter suggest that 
during the electrochemical reduction of RSNOs at voltages between -0.6 V to -0.9 V at 
pH 7.4, NO(g) is not the predominant product.  Instead, the RSNO species are reduced to 
N2O(g) and can only be converted back to NO by switching to a more oxidizing potential.   
Two possible reductive pathways may occur upon the electrochemical reduction 
of RSNOs to explain the production of N2O rather than NO. Further experiments aimed 
at accounting for all the possible electro-reduction reactions that lead to an unexpected 
high number of electrons from coulometric measurements at pH 7.4 are needed before 
final conclusions can be drawn.  However, at pH 4.0, quantitative NO release from 
RSNOs at a gold working electrode does indeed take place at a cathodic potential of -0.8 
V.  Additional experiments aimed at examining and eliminating the surface Au-thiol 
interaction still need to be conducted in order to elongate the life-time of NO release from 
the electro-reduction of RSNOs in the catheter configuration.  Nonetheless, based on 
preliminary results obtain here, it seems possible to use a reservoir of RSNOs at low pH 
to create biomedical devices (e.g., intravascular catheters) in which electrochemically 
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ELECTROCHEMICAL MODULATION OF NITRIC OXIDE RELEASE FROM 




As discussed in Chapter 1, it may be of therapeutic value to design a biomedical 
device that can deliver localized NO with the necessary dose on demand.  Current 







  Generally, photolytic and thermal modulations require the 
NO donor molecules to be light or heat sensitive, and this will cause stability issues 
during the storage and transport/shipping of the medical devices.  With proper design, the 
electrochemical technique can provide a unique method for a generic galvanic and/or 
voltage control to a variety of readily available NO donors.  More importantly, with the 
use of a simple potentiostat, very precise real time current and potential information that 
is associated with the NO release reaction can be obtained and further modulated.  
Therefore, electro-modulation of NO release can provide an alternative method to realize 
quantitative NO release in a better controlled manner.   
This is achieved by using either electrochemically active compounds such as 
RSNOs (Chapter 3) or proton driven NO donors.  It is possible to design controlled 
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NO release from pH sensitive NO donors via an electrochemically modulated proton 
production from aqueous solutions.  Specifically, this approach can be achieved by using 
inorganic nitrite salts and diazeniumdiolates, where production of protons at an anode can 
locally activate NO release.  By tuning the applied potential between working and 
reference electrodes in contact with an appropriate donor reservoir, a novel method of 
creating modulated NO delivery devices may be possible.  This would allow fundamental 
studies to define necessary NO fluxes and NO release frequencies required to achieve 
specific therapeutic effects.   
In theory, water can undergo a four-electron oxidation reaction to generate O2 and 
four protons (oxygen evolution reaction, or OER, Eqn. 4.1), and this is well managed in 
green plants.
6, 7
   
       
       
                                    
Therefore, by applying an oxidizing potential on the working electrode (e.g., Au, Pt, and 
glassy carbon), the local pH will be lowered by generating protons from water oxidation 
in a thin layer in proximity to the anode surface.  However, in practice, the 
electrocatalytic water oxidation described in Eqn. 4.1 has been a challenge and a 
bottleneck in water splitting related research.
8
  This is mainly due to its slow electrode 
kinetics.  For example, while the thermodynamic potential for OER is at 0.62 V (vs. 
Ag/AgCl, unless otherwise stated) at pH 7 and 1 atm O2, the actual electrode reaction 
occurs at a much more positive potential (overpotential, η) that reflects the slow electron 
transfer kinetics.  Such high overpotential will not only cause a partial loss of energy, 
which consequently requires larger power input of medical devices, but more importantly, 
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it will sacrifice some of the locally released NO by electrochemically oxidizing it into 
nitrite (Eqn. 4.2) or nitrate (Eqn. 4.3) ions at the high anodic potential on the working 
electrode.
9
   
             
                                  
               
                             
Scheme 4.1. Possible NO oxidation reaction on the working electrode. 
This will be a critical issue when the released NO has to diffuse through a polymeric 
catheter tubing wall to reach the target site.  Thus, it is necessary to seek a proper 
electrocatalysis surface on which the water oxidation reaction occurs with a minimal 
value of η to yield sufficient proton production and, at the same time, prevent significant 
NO oxidation.  
Fortunately, because of its essential role in splitting water and converting solar 
energy into chemical energy, there are intensive research efforts in OER related studies 
with a broad selection of catalytic electrode materials available.
10
  Despite the active 
research explorations of new surface modifications for materials such as 
semiconductors
11
 (e.g., crystalline silicon, gallium phosphide), our aim is to modify a 
conventional anode surface (Au, Pt, C) that can be easily engineered into a wire 
configuration with a catalyst on it to facilitate OER at lower potentials.  Some metal 
complexes, (e.g., Ir and Ru
12, 13









) can have high oxidation states that will catalyze water oxidation.  Among them, 
iridium oxide was selected in this thesis work as the electrocatalyst for the water 
oxidation on an anode.  Generally, the metal oxide materials can be prepared in different 
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  Recently, the Murray 
group conducted mechanistic studies on achieving the lowest overpotential (η≈0.15 V) 





     
In the work reported in this chapter, the oxidation potential on an anode where the 
water oxidation occurs at the lowest overpotential was optimized (to provide sufficient 
proton generation and to prevent the oxidation of localized NO).  Two different types of 
pH sensitive NO donors, nitrite salts and diazeniumdiolate species, were employed to 







) of localized NO on demand to 
potentially prevent clotting and infections. 
 
4.2 Materials and Methods 
4.2.1 Materials 
Sodium nitrite, sodium chloride, sodium hydroxide, sodium acetate, sodium 
bicarbonate, potassium chloride, potassium phosphate monobasic, sodium phosphate 
dibasic, iron (III) chloride, hydrochloric acid (37%), and potassium hexachloroiridate(IV) 
were obtained from Sigma-Aldrich (Milwaukee, WI).  A fluorescence pH probe, 
LysoSensor™ Yellow/Blue dextran (10,000 MW), was purchased from Life 
Technologies (Grand Island, NY).  Diazeniumdiolates salts including methylamine 
hexamethylene methylamine NONOate (MAHMA/N2O2), spermine/N2O2, and 
proli/N2O2 are products of Cayman Chemical (Ann Arbor, MI). These chemicals were 
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used without further purification unless otherwise noted.  Phosphate buffered saline (PBS) 
and all other solutions were prepared with 18.2 MΩ·cm
-1
 DI water from a Milli-Q system 
(Millipore Corp., Billerica, MA). 
Gold and platinum wires (0.076 mm i.d., 0.13 mm o.d.) with Teflon
®
 coatings 
were obtained from A-M Systems (Sequim, WA).  The silicone rubber tubing (0.51 mm 
i.d., 0.94 mm o.d.) used to construct catheters was purchased from Helix Medial Inc. 
(Carpinteria, CA) and silicone rubber (RTV-3140) was a product of Dow Corning 
(Midland, MI).  Carbon fibers (F22, 24k) were a gift from Toho Tenax America Inc., 
(Rockwood, TN). 
4.2.2 Fluorescence Microscopy pH Measurement  
Widefield single-molecule epifluorescence microscopy was performed as 
previously reported.
25
  In brief, samples were imaged with a 1.40 NA oil-immersion 
objective in an Olympus IX71 inverted microscope and detected on a 512×512 pixel 
Photometrics Evolve EMCCD at a rate of 35 ms/frame. Samples were initially excited 
and then imaged under 488-nm illumination (Coherent Sapphire 488-50). Appropriate 
filters (Semrock 488-nm dichroic filter and Semrock 488-nm long-pass filter) were 
chosen to maximize signal and minimize scattered laser light. 
4.2.3. Preparation of IrOx Nanoparticles 
The 2 nm iridium oxide nanoparticles were prepared as reported.
23, 26
  In brief, 2.5 
mM K2IrCl6 was dissolved in 0.1 M NaOH and heated at 90˚C for 20 min until the brown 
solution turned clear.  The solution was then immediately cooled down in an ice bath, 
forming a light blue solution.  The formation of IrOx nanoparticles was validated by its 
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maximum absorbance at 580 nm using a UV-Vis spectrophotometer (Lambda 35, Perkin-
Elmer, MA).  Each batch of fresh solution was stored in a 4˚C refrigerator and used for 
up to one week. 
4.2.4 Fabrication of Catheters 
A silicone rubber tubing based catheter was prepared for potential in vivo 
implantation and/or biofilm dispersion studies.  Generally, 1 cm of gold was exposed 
from a Teflon
®
 coated gold wire (i.d., 76 μm) with a total length of 6 cm.  Then, similarly, 
2 cm of a Teflon
®
 coated silver wire (i.d. 125 μm) were exposed and oxidized into 
Ag/AgCl as the reference/counter electrode with a total length of 8 cm.  The working 
electrode (Au or Pt) was coiled onto the Ag/AgCl electrode (1 cm and 5 mm apparent 
length after coiling for the working electrode and reference electrode, respectively).  The 
combination electrode was then inserted into a 2 cm silicone rubber tubing (i.d. 510 μm).    
A volume of 3 μL of the buffered sodium nitrite or diazeniumdiolates solution was 
introduced into the silicone rubber tubing without any bubbles (by visual check).  The 
polymeric tubing was sealed with silicone rubber glue (SR 3104, Dow Corning, MI) 
before (distal end) and after inserting the electrodes. A potentiostat (CHI 800B, Austin, 
TX) was used to apply the electrochemical voltage or current required for water oxidation. 
4.2.5 NO Measurement  
Nitric oxide was measured with a real-time chemiluminescence nitric oxide 
analyzer (NOA).  More specifically, in the catheter test, polymeric tubing containing the 
NO releasing agent and a two-electrode circuit was place into a glass cell.  The cell was 
purged with nitrogen.  Nitric oxide was continuously removed from the solution by using 
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a nitrogen bubbler and sweep gas into the reaction chamber.  A combination Echem-
NOA cell that is similar to the one designed in Chapter 3 (Figure 3.1) was used to 
conduct such combined electrochemical reaction and NO monitoring experiments. 
 
4.3 Results and Discussion 
4.3.1 Surface pH Measurements 
An in situ fluorescent measurement was aligned with electrochemical settings to 
prove the production of protons and localized pH change from water oxidation at the 
anode surface.  A LysoSensor™ Yellow/Blue pH dye was employed as the proton probe 
(Figure 4.1).  The LysoSensor™ dye is an acidotropic probe that appears to accumulate 
in acidic conditions as a result of protonation.  This protonation also relieves the 
fluorescence quenching of the dye by its weak base side chain, resulting in an increase in 
fluorescence intensity. Figure 4.2 shows the average fluorescence emission response of 1 
μM dye in different pH buffer solutions ranging from 3 to 7.  A significant increase of 
fluorescence intensity was observed when the pH dropped from 4 to 3.  This probe is a 
sensitive indicator to monitor the local proton production at the surface of an electrode. 
 
 




Figure 4.2. The pH-dependent fluorescence intensity response curve of 1 μM LysoSensor™ Yellow/Blue. 
 
Further, two electrodes (Au working electrode and Ag or Ag/AgCl reference 
electrode) were placed onto a microscope slide within a thin layer of 1 μM LysoSensor™ 
dye in pH 7.4 PBS solution (Figure 4.3a).  To eliminate evaporation of the small volume 
samples (~60 μL), the solution was sealed with a cover slip and glue.  The electrodes 
were connected to a potentiostat (ESA Biosciences Inc., Chelmsford, MA) to apply 
positive potentials to oxidize water and release protons.  The interface between the 
electrode surface and solution was imaged under the microscope (Figure 4.3b).  When an 
anodic potential at +1.5 V (vs. Ag) was applied on the gold wire, an immediate increase 
of fluorescent intensity was observed (Figure 4.3c and d).  Later, the fluorescent emission 
was quenched when the potential was switched to 0 V (Figure 4.3e).  It should be noted 
that by switching to a less positive potential (i.e., +0.8 V), a smaller increase of 
fluorescent intensity was observed.  These results prove that by tuning the anodic 
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potentials, the proton formation near the gold working electrode surface can be 
modulated. 
 
Figure 4.3. a) A picture of the combination echem-fluorescence measurement setup. b) Region of interest 
at the electrode and solution interface. c) Fluorescence image of the interface at 0 V. d) Intensified 
fluorescence image of the interface at +1.5 V. e) Fluorescence image of the interface going back to 0 V 
after d). 
 
4.3.2 Electro-modulation of NO Release from Nitrite Salts 
It is reported that acidified nitrite and NO play an important role in gastric host 
defense against swallowed pathogens.
27
    Indeed, NO can function as an anti-microbial 
agent and is found in the stomach in a range of 10-100 ppm.
28
  Chemically, when nitrite 
(pKa 3.4) is acidified, it produces nitrous acid (HNO2, Eqn. 4.4) first, which 
spontaneously decomposes to nitric oxide (NO, Eqn. 4.5) and nitrogen dioxide (NO2, Eqn. 
4.6).   
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This inspired us to consider employing the proton driven nitrite salts to electrochemically 
release NO by providing protons from water oxidation.  Sodium nitrite is inexpensive and 
stable, and can be prepared at concentrated levels in miniature devices.   
Bulk Solution Test 
First, preliminary bulk solution tests were carried out in 1 M NaNO2 solutions in a 
10 mM phosphate buffered saline at pH 7.0 using a polycrystalline gold disk working 
electrode (dia. 3 mm), a commercial Ag/AgCl reference electrode (in 3 M KCl solution 
behind a frit), and a Pt coil counter electrode.  As shown in Figure 4.4, when a series of 
anodic potentials were applied onto the Au electrode, different amounts of NO are 
released from the acidification of nitrite near the electrode surface.  Starting from +0.75 
V (vs. Ag/AgCl), apparent NO release is observed, and by turning the potential to 0 V, 
the amount of NO decreases back to baseline.  When the potential is switched from 0 V 
to +0.8 V, a significant amount of NO is released immediately.  At the same time, by 
holding the anodic potential at +0.8 V for 30 min, a relatively constant release of NO is 




Figure 4.4. Nitric oxide release from the acidification of 1 M NaNO2 in 10 mM PBS (pH 7.0) at a gold 
disk electrode surface with pulsed potentials applied. 
 
Catheter Test 
Further, a miniature catheter device was created based on the successful bulk 
solution test results.  Figure 4.5 shows a schematic diagram of the catheter configuration, 
where Teflon
®
 coated gold and Ag/AgCl wires were employed as the working and 
reference electrodes, respectively.  The thin wires were coiled together and inserted into 
small silicone rubber tubing that was filled with buffered 100 mM NaNO2 solution, and 




Figure 4.5. Schematic representation of the electrochemically modulated NO release catheter configuration, 
using a gold working electrode and NaNO2 as the NO precursor. 
 
 
In the catheter testing, a significant amount of NO is released when a positive 
potential at +0.75 V (vs. Ag/AgCl) is applied on the Au electrode (Figure 4.6a) for 2 h.   







.  However, the flux of NO gradually decreases even though a constant anodic 
potential was applied on the Au electrode.  At the same time, the anodic current observed 
on the working electrode decreases concurrently.  This indicates that the potential applied 




Figure 4.6. a) Nitric oxide released from a catheter containing 100 mM NaNO2 in 10 mM PBS (pH 7.0). 
The potential was kept at +0.75 V on a small gold wire electrode surface for 2 h. b) The corresponding 
anodic current on the gold working electrode. 
 
 
Indeed, it was observed that the color of the Ag/AgCl reference electrode turned 
from black to white at the end of the 2 h experiment, indicating that the AgCl layer is 
degraded due to the large current (μA) passed through this reference and counter 
electrode.  Therefore, an additional cathodic potential was introduced after the oxidizing 
potential to regenerate the Ag/AgCl layer on the reference electrode.  The potential was 
switched between +0.65 V and -0.20 V (vs. Ag/AgCl), each in a 5 min interval, for 16 h.  
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A relatively longer release of NO (flux>1, for 8 h) from a catheter configuration is 
observed using this modified potential sequence (Figure 4.7).   
 
Figure 4.7. Nitric oxide release from a catheter containing 100 mM NaNO2 in 10 mM PBS (pH 7.0) using 
a small gold wire electrode (dia. 76 μm, 1 cm) and Ag/AgCl (dia. 250 μm, 3 cm), pulsed between +0.65 V 
and -0.20 V (5 min each) for 16 h. 
 
Further, a more stable electrochemical system with an additional large surface Pt 
auxiliary electrode was tested.  In the 3-electrode system, when the potential is kept 
constant at +0.8 V on a gold wire (dia. 76 μm, 3 cm), a stable NO release is observed at 
1.5 ppm (Figure 4.8a) in a bulk solution containing 1 M NaNO2.  The corresponding 




Figure 4.8. a) Nitric oxide release from the acidification of 1 M NaNO2 in 10 mM PBS (pH 7.0) at small 
gold wire electrode surface with at +0.80 V for 2 h. b) The corresponding anodic current on the gold 
working electrode. 
 
Another possible method to prevent the reference electrode from degrading is to 
employ a pseudo reference electrode, such as bare metal wires.  Silver, Au and Pt wires 
were compared and it was found that both Ag and Pt can provide a relatively stable 
potential vs. the working electrode.  Therefore, bare Ag was selected as the pseudo 
reference electrode in a bulk solution test with 1 M NaNO2 (Figure 4.9).  With this 
configuration, well-modulated NO release is achieved for 4 h without a significant drop 
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in the amount of NO.  Later, in a catheter test using phosphate buffered 100 mM NaNO2 
solution, a modulated “on” and “off” NO release pattern is observed for the first 4 h.  
However, a significant decrease of NO flux still occurrs after the 8
th
 hour (Figure 4.10).  
The pH of the filling solution was measured afterwards, and it increased from the initial 
7.0 to 9.4.  This is possibly due to the production of OH
-
 species on the bare Ag electrode. 
 
Figure 4.9. a) Nitric oxide release from the acidification of 1 M NaNO2 in 10 mM PBS (pH 7.0) using a 
small gold wire electrode and bare Ag (dia. 250 μm, 3 cm), pulsed between +1.50 V and 0 V (5 min each) 






Figure 4.10. Nitric oxide release from a catheter containing 100 mM NaNO2 in 10 mM PBS (pH 7.0) using 
a thin gold wire electrode (dia. 76 μm, 3 cm) and Ag/AgCl (dia. 250 μm, 3 cm), pulsed between +1.5 V and 
0 V (5 min each) for a) 4 h and b) 15 h, periods. 
 
One potential disadvantage of using the acidified nitrite salts as an NO donor is 
the production of nitrogen dioxide gas as a byproduct.  Nitrogen dioxide can diffuse 
through the catheter wall, and is an oxidizing radical that can initiate a variety of 





  Therefore, it is necessary to explore other NO donors that will produce less 
or non-toxic side products from the NO release devices. 
4.3.3 Electro-modulation of NO Release from Diazeniumdiolates  
Diazeniumdiolates, a group of organic species containing two molecules of NO 
with an amine (N) or other nucleophilic site, can also release NO upon exposure to 
protons (see mechanism below).   
 
Scheme 4.2. The proton driven NO releasing mechanism from anionic diazeniumdiolates. 
In the optimal catheter design, the NO gas will diffuse through the wall of the polymeric 
tubing, while the residual amine product will stay within the catheter.  This pH sensitive 
NO donor is generally stabilized in the hydrophobic polymer matrix or stored in high 
alkaline solutions.
30
  Therefore, it is possible to prepare water soluble diazeniumdiolates 
in high pH solutions (pH 11 or higher), and then by electrochemically generating protons 
(from water oxidation) in a thin layer proximal to the anode surface, localized NO will be 
released from the diazeniumdiolates molecules nearby.  Another advantage of using 
diazeniumdiolates as the NO donor is that the water oxidation reaction will happen at a 
less positive potential under high pH conditions (to stabilize the donor), provided a good 
buffer is present to maintain the pH of bulk solution. 
Bulk Solution Test 
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As a preliminary experiment, a gold wire working electrode (dia. 76 μm, 3 cm) 
and a bare Ag pseudo reference electrode (dia. 125 μm, 3 cm) were employed in 10 mL 
of 10 mM methylamine hexamethylene methylamine NONOate (MAHMA/N2O2) in a pH 
12 NaOH/KCl solution.  Indeed, at +0.65 V (vs. Ag), an increase of the amount of NO is 
clearly observed.  By further increasing the potential to +1.50 V (vs. Ag), a larger NO 
release is seen (Figure 4.11a).  This suggests that by switching the anodic potential on the 
working electrode, the NO release flux can be tuned.   
 
 
Figure 4.11. a) Nitric oxide release from the acidification of 10 mM MAHMA/N2O2 in NaOH/KCl 
solutions (pH 12.0) using a small gold wire electrode (dia. 76 μm, 3 cm) and a bare Ag (dia. 250 μm, 3 cm). 
The potential was pulsed between anodic potentials (+0.65 V and +1.50 V) and 0 V for 1 h and, b) the 




Other diazeniumdiolates species such as spermine/N2O2 and proline/N2O2 were 
also examined as NO release candidates.  However, due to their instability and sensitivity 
to pH, they failed to provide controlled release of NO from electrochemical modulation.  
For example, proline/N2O2 is very sensitive to proton concentrations and has a half-life of 
1.8 s at 37˚C (pH 7.4).  Therefore, low levels of proline-N2O2 solutions generally start 
with a high NO basal level (i.e., 20 ppb for 1 mM proline/N2O2) in pH 11, making it very 
challenging for precise dosage control.  On the other hand, spermine/N2O2 has a 
relatively longer half-life of 39 min at 37˚C (pH 7.4), and requires more protons to 
sufficiently lower the local pH and initiate NO release.  Hence, MAHMA/N2O2 (half-
life=1 min, 37˚C, pH 7.4) was selected as the most suitable diazeniumdiolate species to 
design the echem-modulated NO release devices.  
Catheter Test 
To test the catheter concept, a reservoir of 50 mM MAHMA/N2O2 solution (in 
NaOH/KCl, pH 12) was placed into a silicone rubber tubing based catheter, along with 
thin wires of the working electrode and the reference electrode.  As shown in Figure 4.12, 
by switching the potential between +0.65 V and 0 V on a Au electrode, NO release can 
be turned “on” and “off” electrochemically.  By applying a constant positive potential 
(+0.65 V) on the working electrode, a constant NO release is achieved.  It is noted that 
the first NO release peak in Figure 4.12 is significantly larger than the second and third 
ones when the same anodic potential was applied.  This is mainly caused by the 
unbuffered solution (NaOH/KCl) used.  When two molecules of NO are released from 
one diazeniumdiolate, one molecule of amine is produced as well.  The NO further 
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diffuses through the wall of the silicone rubber tubing, while the amine stays in the filling 
solution as a scavenger for protons.  To prevent such a titration effect, a good buffer 




Figure 4.12. Nitric oxide release from a catheter containing 50 mM MAHMA/N2O2 in NaOH/KCl (pH 12), 
using a Au wire working electrode (dia. 76 μm, 1 cm) and Ag/AgCl reference electrode (dia. 125 μm, 3 cm). 
The potential was switched between +0.65 V and 0 V. 
 
Carbonate buffer was employed to provide a stable pH in the bulk solution while 
protons were produced close to the surface of the working electrode.  However, as shown 
in Figure 4.13, a decrease in NO release from a carbonate buffered catheter is still 
observed in a 12 h long term experiment.  Only 3% of the total NO is actually released 
from 3 μL of a 50 mM MAHMA/N2O2 solution.  The pH was tested afterwards, and it 
did not exhibit a significant change.  However, the Ag/AgCl reference electrode was 
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again found to be white, indicating possible degradation.  A pseudo bare Ag reference 
electrode was then employed into a long term catheter test; however, similar to the 
previous nitrite salt study, the pH of the solution increased significantly because of the 
formation of OH
-
 at the Ag electrode.   
 
 
Figure 4.13. Nitric oxide release from a catheter containing 50 mM MAHMA/N2O2 in carbonate buffer 
(pH 11), using a Au wire working electrode (dia. 76 μm, 1 cm) and Ag/AgCl reference electrode (dia. 125 
μm, 3 cm), with the potential switched between +0.60 V and 0 V for every 5 min. 
 
4.3.4 IrOx Modified Electrode for Electrochemically Modulated NO Release 
In order to facilitate proton formation at a low anodic potential and prevent 
significant loss of NO from being oxidized on the working electrode, iridium oxide 
nanoparticles were employed as the electrocatalyst.  They were prepared by thermal 
hydrolysis of K2IrCl6 at pH 13 and without addition of stabilizer ligands, as previously 
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reported by the Murray group.
23, 26
   The formation of IrOx particles was verified by the 
UV-Vis spectrum of the prepared solutions, with a λmax at 580 nm (Figure 4.14).   
 
 
Figure 4.14. The UV-Vis spectrum of IrOx nanoparticles dispersed in 0.01 M NaOH solution, with       
at 580 nm. 
 
Further, the oxides particles were electrochemically deposited onto different 
anode surfaces (Au, Pt, and glassy carbon (GC) disk electrode) by an electro-floccuation 
process at +1.3 V (vs. Ag/AgCl) for 10 min.  All Au, Pt, and GC electrodes with the 
conducting film exhibited an increased current as compared to the bare electrodes, and a 
noisy anodic current due to the copious O2 gas evolution.  Among the three electrodes 
examined, GC exhibits the most stable formation of an IrOx layer, and the largest current 
increase over Au and Pt electrodes.  As shown in Figure 4.15, on bare GC, due to high 
overpotential values, the oxygen evolution or proton generation reaction did not occur 
until the potential reaches 1 V (vs. Ag/AgCl).  However, on the IrOx nanoparticle 
modified surface, a more efficient oxygen evolution reaction occurrs at a lower potential 
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of +0.6 V, with a much larger current (~ 8 times).  More importantly, the electrocatalytic 
layer did not exhibit significant NO oxidation when 0.2 mM of NO was added into the 
NaOH solution.  This indicates that in the potential region of +0.6-0.8 V, water oxidation 
can be catalyzed by the iridium oxide nanoparticles without significant loss of NO. 
 
Figure 4.15. Cyclic voltammagrams of a GC electrode scanned between 0-1.5 V (vs. Ag/AgCl) in 100 mM 
NaOH (pH 13): a) on bare glass carbon disk electrode (dia. 4 mm), solid line; b) on GC electrode deposited 
with IrOx nanoparticles, dotted line; c) GC-IrOx electrode scanned in the same NaOH solution with the 
addition of 0.2 mM NO (dashed line). 
 
To further evaluate the NO release enhancement derived from the IrOx 
nanoparticles at lower potential, bare GC (Figure 4.16a) and GC-IrOx (Figure 4.16b) 
electrodes were employed to release NO from a carbonate buffered bulk solution 
containing 1 mM MAHMA/N2O2 at pH 11.  At +0.6 V (vs. Ag/AgCl), the GC-IrOx 
clearly exhibits a higher amount of NO (~ 8 times) from a faster catalytic proton 
production reaction.  It is worth mentioning that the optimal potential for NO release on 
the GC-IrOx was found to be +0.6 V (vs. Ag/AgCl).  This is also consistent with the 
cyclic voltammetry results presented in Figure 4.15, where a significant increase of 
current from the oxygen evolution reaction starts at +0.6 V.  At higher potentials (i.e., 
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+0.7 V and +0.8 V), a decrease of NO is observed, indicating partial oxidation of NO at 




Figure 4.16. Nitric oxide release from a bulk solution containing 1 mM MAHMA/N2O2 in carbonate buffer 
(pH 11), using a GC disk working electrode (dia. 3 mm), Ag/AgCl reference electrode, and a coiled Pt 
counter electrode, with the potential switched between varying anodic potential (0.4-0.8V) and 0 V for 




However, the IrOx film is known to be unstable on most electrode surfaces,
31
 and 
carbon is by far the most suitable material that enables mechanically stable and 
reproducible layers of the oxide particles to reside these on.
32, 33
  Therefore, carbon fibers 
were employed as the anode to provide a flexible electrode to eventually fabricate a 
medically relevant NO release catheter.  Carbon fibers are also a less expensive material 
than the previously used rare metal wires (e.g., Au and Pt). 
First, a 4 cm length of a carbon fiber bundle (dia. 7 μm, 200 threads) was 
examined with a Ag/AgCl (dia. 125 μm, 5 cm) as the reference in a bulk solution of 1 
mM MAHMA/N2O2 in a carbonate buffer solution at pH 11 (Figure 4.17a).  By switching 
the potential on the IrOx modified carbon fiber (CF-IrOx) working electrode between +0.6 
V and 0 V, the NO release is well controlled by the potential.  More importantly, due to 
the better proton generation property of the IrOx catalyst and a larger surface area of the 
carbon fiber electrodes (than the gold wires), a larger amount of NO was released from 
the less concentrated diazeniumdiolate solutions (compare Figure 4.11 and 4.17).  The 
CF-IrOx electrode was also incorporated into a silicone rubber tubing catheter that is the 
same configuration as the previous one (Figure 4.5).   As shown in Figure 4.17b, the NO 
release from the catheter containing 5 times lower concentration of diazeniumdiolate 
donor (10 mM) and the CF-IrOx with a Ag/AgCl reference does indeed achieve a 
comparable NO flux pattern to the previous results using a bare Au wire working 
electrode.  This provides a good indication that CF-IrOx is a suitable electrode material 
for the design of electrochemically modulated NO release devices.   However, more 
research is needed in order to achieve a long term NO release (> 8 h) in a catheter design, 






Figure 4.17. Nitric oxide release from a) 1 mM MAHMA/N2O2 bulk solution in carbonate buffer (pH 11), 
b) a catheter containing 50 mM MAHMA/N2O2 in carbonate buffer (pH 11), using a CF-IrOx wire working 
electrode (dia. 7 μm, 4 cm) and Ag/AgCl reference electrode (dia. 125 μm, 3 cm), with the potential 





In this chapter, it has been demonstrated that it is possible to achieve well 
controlled NO release from pH sensitive NO donors via electrochemical modulation.  
Two types of pH sensitive NO donors were investigated, and a buffered solution 
containing these donors was placed into a silicone rubber tubing catheter as well.  In the 
catheter design, diazeniumdiolates are a more suitable donor candidate, while nitrite salts 
are not appropriate, since they produce a toxic side product, NO2, that can diffuse through 







) can be released from the catheter for up to 8 h.  Additionally, 
iridium oxide nanoparticles were deposited onto a carbon fiber electrode by electro-
fluoccuation.  The modified carbon fiber electrode exhibited a superior ability to release 
larger amounts of NO at a lower anodic applied potential.  Current limitations for this 
research include the degradation of the reference/counter electrode, and consequently a 
relatively short NO release life time.  Future studies will mainly involve searching for a 
more stable and robust reference/counter electrode to carry the large anodic current 
during water oxidation.   A better engineered design to fit a 3 electrode setup into the 
catheter would also provide a stable electrochemical cell for a potentially longer life time 
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5.1 Summary of Results and Contributions 
Electrochemistry-based diagnostic devices have been widely applied in modern 
medicine, especially in point-of-care clinical analysis in hospitals and doctor’s offices.  In 
this Ph.D. dissertation, we have employed miniaturized classical enzyme-based 
electrochemical sensor devices to measure very low concentrations of glucose levels in 
tear fluid using a micro glass capillary tube configuration.  Furthermore, a novel method 
that utilizes electrochemical modulation to deliver nitric oxide (NO) on demand from 
catheter tubing was also described.  This new catheter design can be incorporated in a 
multi-lumen catheter configuration to help prevent clotting and infection of such 
indwelling medical devices. 
In Chapter 2, needle-type amperometric and coulometric sensor devices were 
fabricated based on a previously reported subcutaneous glucose sensor configuration.
1
  
Both amperometric and coulometric sensors were combined with a micro glass capillary 
tube in which only 3 μL of tear fluid was needed to detect the lacrimal glucose 
concentrations.  These electrochemical sensors can reliably measure very low glucose 
levels with a limit of detection of less than 1 μM (0.62±0.03 µM and 0.38±0.13 µM for 
amperometric and coulometric sensors, respectively, S/N=3, n=3) and exhibit excellent 
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selectivity over possible interference species (i.e., ascorbic acid, uric acid, and 
acetaminophen) with less than 10% error at their highest possible concentrations in tear 
fluid.  Further, these miniature electrochemical devices were employed in an anesthetized 
rabbit model to detect the tear glucose levels in live animals and, more importantly, to 
examine whether a correlation between tear glucose and blood glucose concentrations 
exists.  It was found that there was a positive correlation between the lacrimal glucose 
levels and the blood glucose concentrations in a total of 17 (6 under the optimal protocol) 
rabbit studies over a wide range of blood glucose values (3-20 mM).  These results 
provide a good indication that tear glucose measurements may be a supplementary tool to 
assist routine blood glucose monitoring with blood glucometer devices for diabetics.  
However, as found,
2
  separate correlation ratios are still observed in the animal model 
from different rabbit subjects and even from eye to eye, indicating the necessity of pre-
calibrating the tear-blood glucose ratio for each individual in potential real-world 
applications.  Once a correlation is obtained for a given eye, the proper algorithm may be 
employed to use tear glucose values to reflect the corresponding concentration of blood 
glucose. 
In Chapters 3 and 4, a different view on applying electrochemical techniques in 
the biomedical field was focused on improving the biocompatibility of implantable 
medical devices.  This was pursued by designing a novel NO delivery catheter from 
which the amount and duration of NO can be modulated by electrochemical methods.  By 
proper control, NO can be delivered on demand to prevent clotting and infection on the 
surface of polymeric catheters.  In this dissertation, two different electrochemical 
strategies were employed toward this ultimate goal. 
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In Chapter 3, electrochemically active species, S-nitrosothiols (RSNOs), were 
examined as a potential NO donor that can release NO locally by electrochemical 
reduction.  Based on prior literature, NO is the reported common product from 
electrochemical reduction of RSNOs at physiological pH.  However, studies here indicate 
that at pH 7.4, the reduction of RSNOs (-0.6 V to -0.9 V, vs. Ag/AgCl), does not yield a 
significant amount of NO.  Instead, gas analysis suggested that RSNOs are reduced to 
nitrous oxide (N2O) at pH 7.4 and can only be converted back to NO at more oxidizing 
voltages.  Interestingly, at pH 4.0, a direct one-electron reduction of RSNOs appeared to 
occur and generates significant amounts of NO from RSNO species.  Therefore, it seems 
possible to use a reservoir of RSNOs at low pH to create biomedical devices (e.g., 
intravascular catheters) in which electrochemically modulated release of NO can be 
achieved to prevent clotting and infection. 
In Chapter 4, it was shown that it is possible to design controlled NO release on 
demand from pH sensitive NO donors via electrochemical modulation.  The anodic 
potential has been optimized to facilitate the water oxidation reaction to occur at the 
lowest overpotential (to provide sufficient protons and to prevent the oxidation of 
localized NO).  Two different types of pH sensitive NO donors, nitrite salts and 
diazeniumdiolate species, were employed to fabricate an electrochemically modulated 
NO release catheter.  In the catheter design, diazeniumdiolates are a more suitable donor 
candidate, while nitrite salts are not optimal, as they produce a toxic side product, NO2, 
that can diffuse through the catheter wall.  With careful design, a physiologically relevant 






) was released from the catheter for up to 6 h.  
Additionally, iridium oxide nanoparticles were deposited onto a carbon fiber electrode by 
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electro-fluoccuation.  The modified carbon fiber electrode exhibited a superior ability to 
release larger amounts of NO at a lower anodic potential than the bare electrodes.   
 
5.2 Future Work   
5.2.1 Strip-type Electrochemical Tear Glucose Sensor 
The use of miniature electrochemical sensors for tear glucose measurements is a 
novel method with very few reports to date.  However, the current design discussed in 
this dissertation requires 3 μL of tear fluids to be collected into a glass capillary for each 
measurement.  Efforts to utilize the electrochemical sensor design with an even smaller 
sample volume (< 1 μL) to measure the concentrations of glucose in human tear fluid is a 
future direction for this research.  Further miniaturization of the capillary sensors 
described in Chapter 2 would require significant engineering efforts.  However, there 
already are many blood glucometer type electrochemical strips in the commercial market 
that utilize <1 μL of blood samples for accurate measurements of blood glucose.  
Therefore, a logical question to ask is whether any of these already existing electrode 
strips can be used with a high current sensitivity potentiostat to measure the low levels of 
glucose found in tear fluid.   
Indeed, ongoing research by Kyoung Ha Cha in this lab has focused on employing 
such disposable strip-type electrochemical sensors to detect tear glucose with only 0.5 μL 
of solutions collected.  Generally, such strips are pre-coated with two reagents inside: one 
is the enzyme that reacts directly with the glucose molecule to remove its two available 
electrons, and another one is the mediator molecule which takes the electrons from the 
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enzyme to the working electrode surface, where the current signal is monitored via end 
oxidation reaction.
3, 4
  The mediator is usually a small chemical capable of existing in 
both an oxidized and a reduced form, and generally with high electrode kinetics to 
transfer electrons.
5
  In Figure 5.1, a schematic diagram of a commercially available 
generic glucose test strip is shown with the fundamental structural components. 
 
 
Figure 5.1. Diagram of testing tear glucose concentrations using commercially available blood glucometer 
test strips. 
 
A large number of currently available glucose test strips were examined to obtain 
the ideal sensor that can sensitively measure low levels of tear glucose and block the 
electrochemically active interference species as well.  The disposable strip was connected 
to a highly sensitive Biostat potentiostat (ESA Biosciences Inc., Chelmsford, MA) at 
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+0.15 V (vs. Au) for the electrochemical oxidation reaction with minimal errors (<10%) 
from ascorbic acid (100 μM), uric acid (100 μM), and 10 μM acetaminophen (10 μM) of 
their highest possible concentrations in tear fluid.  Using the optimal strip, preliminary 
results from amperometric measurements over a range of low glucose concentrations (0-
800 μM) in pH 7.4 PBS have been observed.  After the sensor was exposed to 0.5 μL of 
glucose solution, an immediate increase of current was observed (Figure 5.2a), and the 
current was recorded at a 5 s mark for each measurement.  The i-t results from low 
concentrations of glucose (0-100 μM) are fitted into a linear regression calibration curve 
in Figure 5.2b.  It is noted that the strip-type sensor exhibits a polynomial regression 
fitting over a wide range of low glucose concentrations (0-800 μM), with a limit of 










Figure 5.2. a) Response curve of single-use strip sensor to different concentrations of glucose (0-100 μM) 
in PBS (pH 7.4) at +0.15 V (vs. Au), each concentration was tested with 3 strips. b) the corresponding 
calibration curve. Error bars represent s.d. of n=3 replicate measurements of each standard solutions. 
 
This strip-type sensor is now employed in an anesthetized animal study protocol 
(see Chapter 2) to evaluate its efficacy of monitoring glucose levels in rabbit tears.  At 
the same time, the blood glucose values are monitored by the commercial whole blood 
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Radiometer instrument so that to examine whether the correlation between tear glucose as 
measured with the strips and blood glucose concentrations exists.   
 
5.2.2 Long-term NO Delivery Catheter 
As a proof-of-concept, it has been demonstrated in this dissertation work that two 
different types of NO donors (RSNO and diazeniumdiolates) can be placed into a silicone 
rubber catheter along with two electrodes to achieve electrochemically modulated NO 
delivery.  However, the current limitation of these systems is the life-time of the NO 
delivery, apparently due to the inability to maintain a truly reliable and durable reference 
electrode.  Therefore, future work should focus on the design of a better reference 
electrode in order to enhance the life time of these catheters (> 12 h). 
First, Ag/AgCl is by far the most successful non-polarized electrode to reliably 
maintain a stable potential in miniature sensor designs.
6
  The AgCl layer is generally 
formed on the surface of bare Ag electrode by chemical (soak in FeCl3/HCl solution) or 
electrochemical oxidation (cycle between 0 to 1 V in HCl solution).  Therefore, it is 
possible to electrochemically regenerate the AgCl layer by simply adding a cathodic 
potential on the working electrode (oxidizing potential on the reference electrode) after 
the water oxidation reaction.   For example, in a catheter that contains diazeniumdiolates 
at pH 11, when an oxidizing potential of +0.6 V is applied on the working electrode, Eqn 
5.1 and 5.3 (Table 5.1) are most likely to occur on the working electrode and reference 
(Ag/AgCl) electrode, producing proton and Ag, respectively.  When a cathodic potential 
is applied on the working electrode at -0.4 V, an oxidizing potential on the reference 
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electrode will possibly facilitate the formation of AgCl(s) (Eqn. 5.7).  Equations 5.3 and 
5.7 are characterized by fast electrode kinetics, meaning that a sufficient high current can 
be passed through the electrode with high efficiency of the redox reaction.  It is observed 
that in a catheter containing 10 mM diazeniumdiolates (MAHMA/N2O2) in pH 11 
carbonate buffered solution, the anodic current at +0.6 V (vs. Ag/AgCl) is twice larger 
than the cathodic current at -0.4 V on a carbon fiber electrode surface.  Therefore, in the 
optimal design, a cathodic potential at -0.4 V (vs. Ag/AgCl) will be turned on for 2 min 
after the potential is kept at +0.6 V for 1 min to regenerate equivalent amount of AgCl 
layer on the Ag/AgCl reference electrode.  
 
 
Table 5.1. Possible half reactions and the corresponding thermodynamic cell potentials on the working 




Additionally, the Ag/AgCl electrode may be better sustained by adding some 
solid AgCl precipitate into the electrolyte solution.  On one hand, the potential of 
Ag/AgCl is determined by the Ag
+
 concentration in solution (           ), which 
is inversely related to the chloride concentration through the solubility product constant 
of AgCl (Ksp= 1.77×10
-10
).  Therefore, in theory, the AgCl precipitate along with a Ag 
electrode can function as a reference electrode, provided a saturated AgCl solution is 
maintained.  Moreover, the low concentration of soluble AgCl in solution can be reduced 
on the Ag/AgCl electrode surface when anodic potential is applied on the working 
electrode (Eqn. 5.3).  In this way, the degradation of AgCl layer on the reference 
electrode surface may be alleviated.  One possible side product yielded from the anodic 
potential sequence is HCl (proton from working electrode and Cl
-
 from reference 
electrode).  However, in the basic solution where diazeniumdiolate is stabilized, the HCl 
can be readily neutralized by high concentrations of OH
-
 nearby. 
Moreover, as described in Chapter 4, stable applied potential sequences can be 
maintained on the working electrode using a pseudo reference electrode (i.e., bare Ag). 
However, the production of OH
-
 species from the reference/counter electrode (from water 
reduction, Eqn 5.6) will titrate the pH of the bulk solution and therefore decrease the 
available amount of protons that react with diazeniumdiolates to release NO.  A possible 
solution for this is to create two separate lumens for the working electrode and the 
reference electrode compartments in a multi-lumen catheter, where the reference 
electrode is in one lumen behind an ion conducting electric pathway (i.e., similar to the 
commercial Ag/AgCl electrode) and the working electrode is in another lumen with the 
NO donor solution (see Figure 5.3).  The reference and working compartments can be 
133 
 
filled with the same buffered solutions to eliminate possible osmolality problems.  In this 
way, the increase of pH from the production of OH
-
 on the pseudo reference electrode 
can be restrained in the reference lumen without changing the pH of the NO donor 
solutions.  Therefore, a longer NO release can be achieved from the working electrode 
lumen that is under a constant pH conditions. 
 
Figure 5.3. a) A schematic configuration of a triple-lumen catheter. b) The cross-section view of two 
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